The role of the receptor tyrosine kinase RET as a dependence receptor during enteric nervous system formation. by Wallace, A.S.
REFERENCE ONLY
UNIVERSITY OF LONDON THESIS
Degree  Year  Name of Author  A- *>
COPYRIGHT
This is a thesis accepted for a  Higher Degree of the University of London.  It is an 
unpublished typescript and the copyright is held by the author.  All persons consulting 
the thesis must read and abide by the Copyright Declaration below.
COPYRIGHT DECLARATION
I recognise that the copyright of the above-described thesis rests with the author and 
that no quotation from it or information derived from it may be published without the 
prior written consent of the author.
LOANS
Theses may not be lent to individuals, but the Senate House Library may lend a copy 
to  approved  libraries  within  the  United  Kingdom,  for  consultation  solely  on  the 
premises  of  those  libraries.  Application  should  be  made  to:  Inter-Library  Loans, 
Senate House Library, Senate House, Malet Street, London WC1E 7HU.
REPRODUCTION
University  of  London  theses  may  not  be  reproduced  without  explicit  written 
permission from  the  Senate  House  Library.  Enquiries should  be addressed  to the 
Theses Section of the Library.  Regulations concerning  reproduction vary according 
to the date of acceptance of the thesis and are listed below as guidelines.
A.  Before  1962.  Permission granted only upon the prior written consent of the 
author.  (The Senate House Library will provide addresses where possible).
B.  1962 -1974.  In many cases the author has agreed to permit copying upon 
completion of a Copyright Declaration.
C.  1975 -1988.  Most theses may be copied  upon  completion of a Copyright 
Declaration.
D.  1989 onwards.  Most theses may be copied.
This thesis comes within category D.
I  I  This copy has been deposited in the Library of  U _____________
— T h i s  copy has been deposited  in the Senate  House Library,  Senate House, 
—   Malet Street, London WC1E 7HU.
C:\Documents and Settings\Iproctor\Local Settings\Temporary Internet Files\OLK8\Copyright - thesis (2).docThe role of RET as a dependence receptor in enteric 
nervous system formation
Adam Spencer Wallace
Thesis submitted for the degree of PhD Developmental Biology
Neural Development Unit 
Institute of Child Health 
30 Guilford Street 
London 
WC1N 1EHUMI Number: U592457
All rights reserved
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did  not send a complete manuscript 
and there are missing  pages, these will be noted.  Also, if material had to be removed,
a note will indicate the deletion.
Dissertation Publishing
UMI  U592457
Published  by ProQuest LLC 2013.  Copyright in the Dissertation  held  by the Author.
Microform  Edition © ProQuest LLC.
All rights reserved.  This work is protected against 
unauthorized copying  under Title  17, United States Code.
ProQuest LLC 
789  East Eisenhower Parkway 
P.O.  Box  1346 
Ann Arbor,  Ml  48106-1346Abstract:
Enteric  neurons  are  derived  from  vagal  and  sacral  neural  crest  cell 
populations.  Using  human  embryonic  tissue  aged  4-14  weeks  of gestation  the 
timing and pattern of gastrointestinal colonisation by vagal neural crest cells, and 
the development of interstitial  cells of Cajal  and  the smooth  musculature of the 
gut, were investigated using immunohistochemistry. Formation of both the enteric 
nervous  system  and  smooth  muscle  involves  rostrocaudal  migration  and 
maturation  of these  tissues.  The  gut  is  fully  colonised  by  neural  crest  cells  at 
week  7  and  these  cells  first  form  the  myenteric  plexus  external  to  the  future 
circular muscle  layer.  Secondary centripetal migration to the submucosal  plexus 
occurs at week 8 in the oesophagus and week  11  in the midgut.  Smooth muscle 
appears at week 8, first as the circular muscle layer, with secondary formation of 
the  longitudinal  layer.  ICCs  are  present  from  week  8  and  develop  in  close 
association with the  myenteric plexus  in the  midgut and  hindgut.  At week  14 all 
components required for a mature gut are present.
Rearranged during transfection  (RET),  a tyrosine kinase receptor and the 
most  commonly  linked  gene  to  the  enteric  nervous  system  developmental 
disorder,  Hirschsprung’s disease,  has  been  described  in  vitro as a dependence 
receptor,  ie:  expression  of  the  receptor  causes  a  cellular  dependency  on  its 
ligand.  In order to test whether RET functions as a dependence receptor in vivo 
constructs  designed  to  perturb  the  caspase  dependent  cleavage  of  RET  were 
introduced by electroporation of neural crest in  E1.5 chicken embryos.  Inhibition 
of Caspase-9 dependent apoptosis reveals a role for cell death in early control of 
neural crest cell numbers.  No effect is observed when  intracellular wildtype RET 
is introduced.  However, introduction of a mutated form of RET induces a delay in 
the  migration  and  differentiation  of  enteric  precursors.  These  observations, 
combined  with  Tunel  and  ret  in  situ  data,  suggest  a  role  for  RET  as  a 
dependence receptor in vivo via a caspase-9 dependent mechanism.
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1.1  The Enteric Nervous System (ENS)
1.1.1 An overview of nervous systems:
The  nervous  system  of  an  animal  is  responsible  for  the  monitoring  of 
internal  and  external  stimuli,  the  processing  of  this  input,  the  generation  of 
original  output  in  higher  organisms,  and  the  coordination  of  the  activity  of 
muscles  and  organs  in  response  to  these  actions  (Stein  1982).  The  central 
nervous  system,  which  comprises  the  brain  and  spinal  cord,  is  responsible  for 
cognition  and  generates  commands  for  the  somatic  portion  of  the  peripheral 
nervous  system.  The  somatic  nervous  system  comprises  afferent  sensory 
neurons  and  efferent  effector  (motor)  neurons  and  is  responsible  for voluntary 
skeletal  muscle  movement.  The  remaining  portion  of  the  peripheral  nervous 
system is the autonomic nervous system which acts to maintain the homeostasis 
of the organism.
1.1.2 The autonomic nervous system
Homeostatic responses are separated from  higher cognitive function  and 
processed by reflex circuits for a rapid response. The autonomic nervous system 
deals  with  these  involuntary  responses  to  stimuli  (Stein  1982).  It  can  itself  be 
further  divided  into  the  sympathetic,  parasympathetic,  and  enteric  nervous 
systems.
10The  sympathetic  (SNS)  and  parasympathetic  (PNS)  nervous  systems 
work synergistically or antagonistically in response to stimuli. As a generalisation 
the  SNS  can  be  thought  of  as  responsible  for  initiating  the  “fight  or  flight”  
response,  and  the  PNS  it’s  opposite,  exerting  an  energy  saving  influence  over 
the muscles and organs it controls.
Independent  of  the  SNS  and  PNS,  the  enteric  nervous  system  (ENS) 
forms  the third  component of the ANS.  Although  capable  of modulation  by the 
SNS and  PNS,  it alone exhibits the ability to operate without extrinsic input.  It is 
this  ability  that  has  earnt the  ENS  the  nick-name  “the  second  brain”   (Gershon 
1999).
1.1.3  The enteric  nervous system, a component of the autonomic  nervous 
system
The enteric nervous system consists of a twin coaxial network of neurons 
and glia that are located in the wall of the gastrointestinal tract. This arrangement 
of  cells,  extending  from  the  oesophagus  to  the  terminal  portion  of  the 
gastrointestinal  tract,  rivals  the  spinal  cord  in  terms  of  number  of  neurons 
(Furness and Costa 1987).
Enteric  ganglia  contain  sensory  and  effector  neurons  like  other 
components of the ANS.  However, they also contain interneurons that form local 
circuits  with  sensory  and  motor  neurons  allowing  the  ENS  to  function 
independently of extrinsic input.  Enteric neurons more closely resemble neurons
liof the central nervous system than those of the ANS,  using glia, cells analogous 
to astrocytes, instead of sheath cells to provide physical and nutritional support.
1.1.4  Structure of the ENS
Enteric neurons and their supporting glial cells are arranged into two plexi 
of ganglia at differing levels within the gut mesenchyme (Fig 1.1). The outermost 
plexus is known as the myenteric (or Auerbach’s) plexus and is located between 
the  longitudinal  muscle  layer,  towards  the  outside  of the  gut,  and  the  circular 
muscle  layer.  Between  the  circular  muscle  layer  and  the  mucosa  is  the 
submucosal or (Meissner’s)  plexus.  Some model  organisms,  such  as zebrafish, 
used  to  investigate  the  development  of  the  ENS  do  not  possess  this  second 
plexus  and  have  only the  myenteric plexus  (Shepherd  et al.  2004).  Under high 
magnification these plexi appear as web-like structures of interconnected ganglia 
comprising tight groups of cells (Fig 1.2).
The  myenteric plexus,  as  indicated  by its  existence  as the sole  neuronal 
layer found  in  more  primitive organisms,  was  probably the first to arise early  in 
the  evolution  of  chordates.  It  can  be  found  along  the  full  length  of the  gut  in 
mammals  and  avians.  The  submucosal  plexus  by  contrast,  is  not found  in  the 
stomach  although  it  is  present  throughout  the  remainder  of  the  gut.  The 
myenteric  plexus  contains  larger  and  more  numerous  ganglia  than  the 
submucosal  plexus at any specific point of gut (Gabella and Trigg  1984;  Burns, 
Pasricha, and Young 2004).
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Figure 1.1: Organisation of the gut layers.
The  myenteric  plexus  lies  between  the  two  main  muscle  layers  of the  gut,  the 
outer longitudinal  layer and the inner circular layer.  The submucosal  plexus  lies 
between  the  circular  muscle  layer and  the  mucosa,  which  lines  the  gut  lumen. 
(Modified from Furness and Costa,  1987)
Figure  1.2:  NADPH-diaphorase  staining  of  chick  hindgut  at  E14.5,  myenteric 
plexus.
(A)  Low  magnification  of  NADPH-diaphorase  staining  of  nitric  oxide  synthase 
containing  neurons at E14.5  in the developing  chick gut.  (B)  Same region of gut 
as in  (A) shown  at higher magnification.  Individual  NADPH  stained  neurons can 
be identified (arrowheads).
Scale Bars: (A) 50pm, (B) 10pm
131.1.5 Function of the ENS
The  ENS  commands  a  wide-ranging  set  of  biological  processes.  These 
include  control  of  contractions  and  relaxations  by  the  circular  and  longitudinal 
muscle layers thus creating peristaltic movement, homeostatic secretions into the 
lumen  of the gut to control  its microenvironment;  control  of the  mucosal  lining’s 
regeneration  in  response  to  continual  wear;  and  interactions  with  the  immune 
system to defend  against  infection  and  parasitic organisms  (Furness and  Costa 
1987).
141.2 The Neural Crest
1.2.1 The neural crest
The  neural  crest  is  a  transient  population  of cells  unique to  vertebrates. 
Arising  from  an  epithelial  to  mesenchymal  transition  during  neural tube  closure 
the neural crest is located dorsal to the neural tube (Fig 1.3). Cells migrate from 
this  location early  in  development and  give  rise to various  cell types throughout 
the  body,  including  neurons  of the  PNS,  the adrenal  medulla,  schwann  cells  of 
the  ANS,  neural  crest-derived  endocrine  organs,  melanocytes,  craniofacial 
structures,  cardiac outflow septum,  and  neurons and  glia  of the enteric nervous 
system (Le Douarin and  Kalcheim  1999).  Migration from the dorsal aspect of the 
neural tube by neural crest cells occurs along stereotypical pathways dependent 
upon the tissue target.
1.2.2 The neural crest gives rise to the ENS
The  neural  crest  was  identified  as  the  origin  of  ENS  precursors  half  a 
century ago.  Using the chick embryo as a model,  the effects of ablating various 
levels  of  neural  tube,  and  associated  neural  crest  were  assessed.  It  was 
discovered  that  removing the post-otic hindbrain  leads to aganglionic gut in the 
developing embryo (Yntema and Hammond  1954). This region, termed the vagal 
crest,  was further specified  following  the development of a  xenograft technique 
developed by Le Douarin in the 1960’s which employed chicken embryos hosting 
quail tissue.
15Figure  1.3: Formation of the neural tube and associated  neural crest.
The  neuroectoderm, which  originally forms a sheet (light blue and green) above 
the  notochord  (red),  elevates  about the  midline.  The  two  opposing  neural  folds 
meet  at  the  region  joining  the  presumptive  neural  crest  (green)  and  the  future 
ectoderm (dark blue). At this point the neuroectoderm destined to become neural 
crest  undergoes  an  epithelial-mesenchymal  transition.  Fusion  of the  ectoderm 
and neural tube (light blue) occur,  resulting in the tube-like structure of the neural 
tube  and  the  sheet  of  ectoderm  above.  Between  these,  the  neural  crest 
completes its transformation before migrating away from the dorsal aspect of the 
neural  fold.  Modified  from  UCLA  -  Crump  Institute  web  notes. 
www.crump.ucla.edu
16The  success  of this  technique  is  due  to  the  similar  size  and  incubation 
period of the two species. Once transplanted quail cells can successfully migrate 
along  their  prescribed  pathways  and  be  incorporated  into  host  tissue.  At  any 
stage  after  surgery  chick  and  quail  cells  can  be  easily  distinguished  by  the 
denser  heterochromatin  appearance  within  the  nucleus  of  quail  cells,  before, 
during  and  after their  migratory  phase.  More  recent  developments  in  antigenic 
markers  of  quail  cells  have  led  to  the  use  of  the  guail  non-chick  gerinuclear 
antibody  (QCPN)  to  identify  all  quail  cells  (developed  by  Carlson  &  Carlson, 
University  of  Michigan,  1989;  see  Developmental  Studies  Hybridoma  Bank  for 
details,  www.uiowa.edu/~dshbwww/),  further  simplifying  and  accelerating  the 
investigative  process.  This  ability to  differentiate  between  the  host  and  grafted 
tissue  allowed  Le  Douarin  to  refine the  precise  axial  level  responsible for  ENS 
precursors  (Le  Douarin  and  Teillet  1973).  Le  Douarin  and  colleagues  identified 
the region between somites one and seven as the main source of vagal derived 
ENS  precursors.  They  also  identified  a  second  source  of  crest  cells  that 
contributed  to  a  lesser extent,  and  specifically  to  the  hindgut,  arising  from  the 
sacral region caudal to the 28th  pair of somites (Fig 1.4).
17Figure  1.4:  Vagal  and  sacral  neural  crest  contribution  to  the  enteric  nervous 
system in the chick embryo.
Vagal  neural  crest cells from the  level  of somites  1-7 colonise the full  length  of 
the  gastrointestinal  tract  (Blue  arrow  and  shading).  Sacral  neural  crest  cells, 
originating  from  the  region  caudal  to  somite  28,  form  the  nerve  of  Remak  and 
then populate the colon and distal intestine (Green arrow, and dots). 
Oes=Oesophagus,  Pro=Proventriculus,  Sto=Stomach,  PD=Pancreatic  Ducts, 
Umb=Umbilicus, Cae=Caecum, Clo=Cloaca, RN=Nerve of Remak1.2.3 Vagal neural crest
Since  Le  Douarin’s  studies  in  the  1970’s,  the  contribution  of  the  vagal 
neural  crest to the  ENS  has  been  confirmed  by regional  ablations of the  neural 
tube in the chick (Peters-van der Sanden et al.  1993), by quail-chick grafts (Burns 
and  Douarin  1998;  Burns  and  Le  Douarin  2001;  Burns,  Champeval,  and  Le 
Douarin  2000),  and  by the  use of viral  cell  labelling with  the  LacZ marker gene 
(Epstein et al.  1994).  Within this area further grafts of smaller sub-regions  have 
revealed  the  target  zones  of three  groups  of cells  (Burns,  Champeval,  and  Le 
Douarin 2000).  Crest at the level of somites one and two contributes exclusively 
to the foregut,  consisting  of the oesophagus and  stomach.  Grafts from  somites 
six to  seven  populate  mainly the  hindgut.  Crest from  the  intermediate  somites, 
three  to  five,  colonise  the  entire  length  of the  gut  from  oesophagus  to  distal 
colon.  This  last  group  provides  the  majority  of  ENS  precursors  (Burns, 
Champeval,  and  Le  Douarin  2000;  Epstein et al.  1994).  In  addition to the  ENS, 
cells from the vagal neural crest also form  parts of the cardiac outflow tract and 
melanocytes.  Neural  crest  derived  cells  from  this  region  migrate  along  two 
different pathways depending upon their target tissue (Fig 1.5).
Investigating  the  behaviour of mammalian  vagal  crest  has  involved  cell- 
labelling techniques such  as  use of transgenic mice  (Kapur,  Yost,  and  Palmiter 
1992),  the  lipophilic  marker  Dil  (Pomeranz,  Rothman,  and  Gershon  1991)  or 
retrovirally delivered  LacZ (Serbedzija and  McMahon  1997)  into the  neural tube 
and neural crest cells. Mammalian systems are not well suited to ablative surgery 
as  they  develop  in  utero,  and  the  extra-embryonic  membranes  must  be  kept
19intact  for  effective  embryo  culture.  However,  vagal  cells  have  been  found  to 
contribute to the  ENS  as they do  in the chicken  (Durbec et al.  1996b),  but with 
some minor differences in the specificity of axial  levels within this domain.  Crest 
at the  level  of somites  six  and  seven,  which  Durbec  refers to  as  anterior trunk 
neural  crest,  gave  rise  to  only  foregut  ganglia  and  dorsal  root  ganglia.  The 
remaining  vagal  region,  between  somites  one  and  five,  gives  rise  to  enteric 
ganglia along the full length of the gut.
|   Ectoderm  H   Neural Tube  H   Notocord
|   Neural Crest  □   Mesoderm  H   Endoderm
Figure 1.5: Migratory routes taken by early neural crest at rhombomere 7.
Early migratory crest cells from  the  region  of rhombomere  7  migrate via  one of 
the two routes shown above;  1) dorsoventral, 2) lateral. The lateral route is taken 
by neural crest cells destined to become melanocytes . The dorsoventral route is 
followed by those populations destined to form the ENS.
20The  pattern  of  migration  by  the  vagal  crest  has  been  found  to  differ 
between  the  various  animal  models  used  to  investigate  ENS  development. 
Zebrafish,  the  use  of which  has  arisen  more  recently  than  that  of  mouse  and 
chick,  have  a  relatively  simple  ENS  comprising  a  single  plexus,  the  myenteric, 
which  arises  from  vagal  neural  crest  cells  which  migrate  in  a  rostro-caudal 
direction, colonising the entire length of the gut (Shepherd et al. 2004).
The vagal  NCC  of mice  migrate  in  a  rostro-caudal wave through  the  gut 
mesenchyme  in  a  region  corresponding  to the  future  position  of the  myenteric 
plexus. Centripetal migration towards the submucosa takes place as a secondary 
event with projections extending through the circular muscle layer.  Rostro-caudal 
colonisation  of the  myenteric  plexus  begins  at  E9.5  and  is  complete  by  E14.5 
(Kapur,  Yost,  and  Palmiter  1992;  Woodward  et  al.  2000;  Young  et  al.  1998). 
Migration from the myenteric plexus to the submucosa occurs at E18.5.
Avian vagal crest migration patterns differ from those of mammals.  Initially 
vagal  cells  follow  the  same  myenteric  route  as  seen  in  mice.  Caudal  to  the 
caecum this changes and they migrate along the  remaining  length of the gut in 
the prospective submucosal region (Burns and Douarin 1998).
211.2.4 Sacral neural crest
The  contribution  of  sacral  crest  to  the  ENS  was  initially  overlooked  but 
once  reported  sparked  a  quarter century’s  worth  of research  to  clarify  its  role. 
Yntema  and  Hammond  did  not  observe  any  enteric  neurons  in  the  chick  gut 
when the vagal region was ablated, and so it was initially assumed that the ENS 
was derived from  a single source (Yntema and  Hammond  1954).  However,  use 
of the quail-chick grafting involving transplantation of the quail neural tube caudal 
to the  28th   pair of somites  into  a  chick  host,  allowed  Le  Douarin  and  Teillet to 
identify quail derived  cells within enteric ganglia  in the  hindgut (Le  Douarin  and 
Teillet  1973).  For  twenty-five  years  conflicting  findings  concerning  the  precise 
contribution made by sacral crest to the ENS were reported.
Labelling sacral  NCC with  Dil  and with  retroviral  introduced  LacZ showed 
there to be sacral derived cells in the hindgut two days prior to the arrival of vagal 
derived cells in the chick (Pomeranz and Gershon  1990;  Serbedzija et al.  1991). 
The  contribution  of sacral  NCC  to  enteric  ganglia  appears  greater  in  the  chick 
than in the mouse but both have been found to contain labelled cells in the post- 
umbilical intestine (Serbedzija et al.  1991). Transplantation experiments in which 
hindgut was  dissected  and  cultured  prior to the  arrival  of vagal  crest  produced 
conflicting results.  Some groups reported a complete absence of enteric neurons 
in the cultures (Nishijima et al.  1990;  Kapur, Yost,  and  Palmiter 1992; Young  et 
al.  1998; Young et al.  1996;  Lecoin, Gabella, and  Le Douarin  1996), while others 
reported  the  presence  of  neurons  (Kapur 2000;  Pomeranz  and  Gershon  1990;
Pomeranz,  Rothman,  and  Gershon  1991),  but in  reduced  numbers.  The  lack of
22neurons  observed  in  these  isolation  and  culture  studies  may  have  been  due to 
the sacral population not having reached the gut at the time of dissection.
This  issue  was  resolved,  for  avian  species,  by  a  comprehensive  study 
utilising  quail-chick  grafting.  Burns  and  Le  Douarin  utilised  sacral  grafts  to 
address  not  only the  presence  of sacral  derived  enteric  ganglia  in  the  gut,  but 
also  the  timing  of  their  colonisation  and  their  fate  (Burns  and  Douarin  1998). 
These studies showed that enteric precursors originating from the sacral crest do 
not migrate directly into the gut.  Instead they first migrate and form the nerve of 
Remak,  then  undergo  a  period  of  migratory  senescence  before  undergoing  a 
second  period of migration  resulting  in  colonisation  of the gut several days  later 
(Burns and Douarin 1998). The nerve of Remak, which is unique to avians, exists 
in close proximity to the mid and hindgut and plays a role in the regulation of gut 
motility through extrinsic projections (Smith and  Lunam  1998;  Lunam and  Smith 
1996). The formation of this nerve occurs as a distal-proximal migration between 
E4.5 and E6. Sacral derived NCCs appear in the myenteric plexus of the hindgut 
at  E7.5,  closely  associated  with  fibres  originating  from  the  nerve  of  Remak. 
Between E7 and E10 sacral derived NCC are closely associated with these nerve 
fibres although they do not appear within enteric ganglia until E10.  From E10 the 
number of sacral  derived  NCC  in the gut begins to  increase  and  contributes to 
enteric ganglia in larger numbers (Burns and Douarin 1998).
231.2.5  The relative invasive capacities of vagal and sacral crest
The contribution of sacral derived NCC to enteric ganglia of the hindgut is 
considerably less than that from the vagal  population. At E16 the percentage of 
QCPN  positive quail  neurons, following a sacral graft,  ranged from  17.4% in the 
distal-colorectum to 0.3%  in the  rostro-colorectum for the myenteric plexus,  and 
1.3% to 0.1%  in the submucosal  plexus  (Burns and  Douarin  1998).  In  embryos 
lacking  the  vagal  contribution  in  the  hindgut  due  to  ablative  surgery,  sacral 
derived  crest  cells  successfully  migrated  into  the  hindgut  and  differentiated 
(Burns,  Champeval,  and  Le  Douarin  2000).  The  number of sacral derived  cells 
present in vagal-deficient hindgut exceeded the number in control gut, by a small 
but  statistically  significant  degree.  However,  despite  increased  sacral  derived 
NCC numbers, enteric ganglia in this region were infrequent and  reduced in size 
indicating that sacral crest is incapable of adequately compensating for a lack of 
vagal cells.
To investigate the different behaviours and invasive capacities of the vagal 
and  sacral  derived  crest,  vagal-to-sacral  and  sacral-to-vagal  grafts  have  been 
performed  (Burns,  Delalande,  and  Le  Douarin  2002).  When  transplanted  to the 
sacral  region,  vagal  cells  successfully colonised  the  hindgut but with  significant 
differences to the patterns seen in controls.  Migration of these transplanted cells 
appeared  more  rapid,  colonising  the  mesenchyme  of the gut at  E4  having  only 
formed a rudimentary nerve of Remak. Control embryos possessed no crest cells 
in the  hindgut  mesenchyme  at this stage  and  the  only quail  cells  present were 
adjacent to the gut wall as nerve of Remak precursors.
24Vagal  cells transplanted  to the  sacral  region  migrated  in  a  caudal-rostral 
direction  in  opposition  to  the  endogenous  vagal  cells  migrating  caudally. 
Transplanted  cells  colonised  the  hindgut,  post-umbilical  intestine  and  some 
reached  the  pre-umbilical  intestine.  These  cells  appeared  to  constitute  the 
majority  of  neurons  and  glia  in  the  myenteric  and  submucosal  ganglia.  Sacral 
cells transplanted to the vagal region failed to fully colonise the gut. These cells 
migrated  to  the  level  of  the  pre-umbilical  intestine,  with  the  majority  of  cells 
present  in  the  myenteric  plexus  although  a  few  cells  were  present  in  the 
submucosal  plexus.  This  implies  that  both  vagal  and  sacral  derived  crest  are 
capable  of  responding  to  rostral  and  caudal  migration  signals.  However,  they 
differ in their ability to generate numbers of neurons and glia.
1.2.6  Developmental disorders affecting neural crest cells
Neurocristopathies  are  conditions  resulting  from  defects  in  neural  crest 
migration,  survival  or  proliferation.  Two  main  types  of  neurocristopathy  exist; 
neural crest tumours and those conditions which  result from a failure of NCC to 
migrate to their targets  successfully.  The  affected  structures  in  these  disorders 
are commonly the adrenal medulla,  Schwann cells of the ANS and  neural crest- 
derived endocrine organs. Tumour type neurocristopathies may affect endocrine 
tissue  or  the  nervous  system,  and  include  conditions  such  as 
pheochromocytoma,  neuroblastoma,  medullary  carcinoma  of  the  thyroid, 
carcinoid  tumours,  and  neurofibromatosis.  Defects  in  NCC  migration  along  the 
gut result in Hirschsprung’s disease, characterised by an absence of ENS cells in 
varying  lengths  of the  hindgut.  Conditions  arising  from  migrational  defects  also
25include  Waardenburg  syndrome,  Aorticopulmonary  septation  of the  heart,  cleft 
lip/palate,  frontonasal  displasia,  and  Di  George  syndrome.  Of  these, 
Waardenburg  syndrome  (WS),  which  involves  failures  in  migration  of 
melanocytes  and  is  characterised  by  a  white  forelock,  is  most  commonly 
associated with HSCR (Pingault et al.  1998).
261.3  Hirschsprung’s Disease -  pathology and treatment
1.3.1  Hirschsprung’s Disease
Hirschsprung’s  disease  (HSCR)  is  the  most  common  congenital  defect 
affecting  the  gastrointestinal  tract.  First  described  by  Harald  Hirschsprung  in 
1886,  HSCR  affects  1   in  5,000  live  births,  although  this  frequency  may  range 
from  1-3  in  10,000,  depending  upon the ethnicity of the study population.  Some 
exceptional,  genetically  isolated  populations  such  as  the  Mennonites  display 
rates ten times higher than this (Carrasquillo et al. 2002).
Most cases  of  HSCR  are  diagnosed  soon  after birth,  but teenagers  and 
adults may also be diagnosed  if suffering  milder forms.  Generally an abdominal 
swelling  (Fig  1.6)  associated  with  failure  to  pass  meconium  within  the  first 
twenty-four to  forty-eight  hours  of  birth  and  vomiting  of  bile  indicate  HSCR  in 
newborns.  Young  children  and  adults  suffering  mild  HSCR  may  be  diagnosed 
after  suffering  prolonged  periods  of diarrhoea  and  constipation,  and  they  may 
also suffer anaemia.
Examination of the gut in HSCR cases reveals a grossly distended length 
of bowel proximal to a stretch of apparently normal gut,  varying  in  length, which 
extends to the anus.  Closer inspection of the distal gut reveals a  lack of enteric 
innervation. With no control exerted over the musculature in this region a state of 
permanent contraction results, causing a blockage and  proximal swelling.  HSCR 
always affects the most distal gut although the aganglionic length varies affecting 
just  the  distal  colon,  known  as  short-segment  HSCR,  or  the  entire  colon  and
27some  of  the  distal  intestine,  termed  long-segment  HSCR.  Eighty  percent  of 
HSCR patients suffer from the short-segment form (Passarge 1967; Garver, Law, 
and  Garver  1985).  Some  cases  of  total  intestinal  aganglionosis  have  been 
reported  (Seri  et al.  1997)  but such  cases are extremely  rare.  Other conditions 
may be associated with HSCR, and are discussed below.
Fig 1.6: Hirschsprung’s disease causes abdominal swelling.
(A)  Neonate  with  swollen  abdomen  due  to  Hirschsprung’s  pseudo-obstruction 
(Photograph courtesy of Dr.  P.Milla).  (B) Region of contracted aganglionic bowel 
(arrowhead)  and  preceding  distension  of gut due to failure of faecal  material to 
pass.
281.3.2 Treatment of HSCR
HSCR  can  be  diagnosed  using  several  techniques.  Rectal  biopsies  may 
be carried out to assess the presence of ganglia although this is more often used 
to  gauge  the  best  point  for  resectioning  the  bowel.  Barium  enemas  and 
abdominal x-rays  allow for a  relatively easy and  low risk  identification  of HSCR 
cases.  Once  identified,  surgery  is  performed  to  remove  the  aganglionic  region 
and  reconnect  the  functional  bowel  to  the  anus.  Three  forms  of  surgery  (the 
definitive  treatment  for  HSCR)  can  be  used  to  restore  gut  function,  each 
successful but differing in the potential complications that can result.
Orvar Swenson proposed the first form of surgery in 1948. He performed a 
resectioning  of  the  bowel  removing  the  affected  portion  and  connecting  the 
dilated segment to two or three centimetres of the distal rectum. Two years later 
Duhamel  began  performing  operations  in  which  normally  innervated  colon  was 
incorporated  into an  aganglionic rectum  resulting  in  a  new rectum  composed  of 
half aganglionic and half ganglionic musculature. Most recently Soave introduced 
the technique of the endorectal pull-through. This  process  involves stripping the 
mucosa from the distal aganglionic rectum and  passing the normally innervated 
colon  through  the  sleeve  of  dysfunctional  rectum.  The  function  of  the  normal 
portion is used to propel material through the abnormal cuff.
These  surgical  procedures  are  not  without  their  faults.  Five  percent  of 
recipients  of  Swenson’s  surgery  experience  anastomotic  leaks.  Duhamel’s 
surgery  is  prone  to  incomplete  emptying  of  the  aganglionic  pouch.  Soave’s
29treatment,  although  avoiding  anastomotic  leaks,  suffers  cuff  abscesses  and 
patients may require continued dilatations.
Ideally  a  method  for  repopulating  this  most  terminal  region  using 
recovered  precursor cells  from  fully functional  bowel,  and  its  incorporation  into 
the  functional  extant  ENS  could  be  used  to  support  the  surgical  procedure. 
Subsequent to the standard surgery the most terminal region would be subject to 
either a  stem  cell  or gene therapy approach that could,  perhaps with  additional 
courses  of  therapy,  restore  functionality  and  result  in  a  more  satisfactory 
standard  of  life.  To  this  end,  an  investigation  of  the  signalling  pathways 
controlling the formation of the enteric nervous system  is desirable  in order that 
we  might  better  understand  the  conditions  required  for  such  a  therapy  to 
succeed.
1.3.3  Genetics of HSCR
HSCR arises from mutations in several known genes and does not display 
simple  Mendelian  inheritance.  Whilst  originally  believed  to  be  a  multifactoral 
autosomal  recessive  disease,  increases  in  patient survival  to  child-bearing  age 
changed  this  idea  as  reports  began  to  appear of familial  cases  consistent with 
autosomal  dominant  inheritance  of  HSCR  (Lipson  and  Harvey  1987;  Lipson, 
Harvey, and Oley 1990; Carter, Evans, and Hickman  1981). Variable penetrance 
and  severity of HSCR cases  indicates a complex and  multifactoral  origin  of this 
condition.  Overall  males  display  higher  levels  of  penetrance  than  females,  4:1
30(Badner  et  al.  1990),  although  within  families  affected  by  HSCR  this  sex  bias 
decreases as the severity of cases increases (Holschneider and Puri 2000).
HSCR occurs as an isolated trait in 70% of cases, while 18% are linked to 
other  congenital  defects.  A  higher  proportion  of  familial  cases  appears  to  be 
associated  with  secondary  congenital  defects  than  for  spontaneous  HSCR. 
Several  defects,  including  cleft  palate,  polydactyly,  cardiac septum  defects  and 
craniofacial abnormalities, display higher than expected incidence within the 18% 
of cases associated with other defects (Spouge and  Baird  1985). The remaining 
12% of HSCR cases are  linked to chromosomal abnormalities of which the vast 
majority are trisomy 21  (90%).
Several  genes  have  been  associated  with  HSCR  cases  in  humans  and 
others  have  been  observed  to  create  HSCR-like  hypoganglionosis  or 
aganglionosis  in  mutant  mice.  The  key genes  associated  with  HSCR  are  RET, 
GDNF,  GFRcd,  ET-3,  EDNRB,  ECE-1,  SMADIP-1,  Phox2B  and  Sox10.  RET  is 
implicated in the majority of identified  HSCR cases, with around a half of familial 
and a third of spontaneous cases having mutations in this gene (Seri et al.  1997) 
(Table 1.1).
31Table  1.1:
Gene Product Species with 
known mutants
Frequency in 
HSCR
RET Co-receptor for GDNF Mouse, Human 20-25%
GDNF Primary ligand for 
RET/GFRa1
Mouse, Human Unknown (rare)
GFRal Co-receptor for GDNF Mouse Not Significant
NTN Ligand for RET Human Single family
EDNRB Receptor for ET-3 Mouse, Rat, Human 5-10%
ET-3 Ligand for EDNRB Mouse, Human 5-10%
ECE-1 ET-3 converting enzyme Mouse, Human Rare
Sox10 Transcription factor Mouse, Human <5% (limited data)
SMADIP-1 Transcription factor Mouse, Human Rare*
Phox2B T  ranscription factor Mouse, Human Rare
* Higher incidence rate in cases displaying HSCR and mental retardation. 
Modified from Kapur RP, Gut 2000 December; 47 Suppl 4:iv 81-83.
321.4 Genetic pathways associated with HSCR and gut aganglionosis
1.4.1 The RET Pathway
1.4.1.1  Receptor Tyrosine Kinases
Receptor  tyrosine  kinases  (RTKs)  are  transmembrane  glycoproteins 
responsible  for  the  transduction  of  signals  for  cell  differentiation  and  growth 
(Schlessinger  and  Ullrich  1992).  All  multicellular  organisms  examined  thus  far 
have  been  shown  to  possess  RTKs,  with  fifty  having  been  described  in 
vertebrates  alone.  RTKs  are  organised  into  groups  according  to their structural 
properties  rather  than  by  their  function.  However,  structurally  related  RTKs 
appear  to  have  similar  roles.  Amongst  the  ligands  identified  for  RTKS  are 
ephrins,  epidermal growth factor (EGF),  fibroblast growth factor (FGF),  glial  cell 
line-derived  growth  factor  (GDNF),  insulin,  nerve  growth  factor  (NGF),  platelet 
derived  growth  factor  (PDGF)  and  vascular  endothelial  growth  factor  (VEGF) 
(Hubbard and Till 2000).
RTKs usually consist of an extracellular ligand binding domain, which may 
be  glycosylated,  linked  to  the  cytoplasmic  signalling  domain  by  a  single 
transmembrane  alpha  helix.  The  extracellular  portion  can  contain  a  variety  of 
discrete globular domains  including  immunoglubulin  (Ig)-like domains,  EGF-like 
domains,  fibronectin  type  Ill-like  domains  and  cysteine  rich  domains.  The 
organisation  of the  intracellular domain  is  simpler comprising  a juxtamembrane 
region, then the tyrosine kinase domain and finally the carboxy-terminal region.
33Two  processes  are  required  for  the  activation  of  RTKs,  namely  the 
enhancement  of  intrinsic  catalytic  function  and  the  creation  of  binding  sites  to 
recruit downstream signalling proteins. In order to be activated, a RTK undergoes 
essential autophosphorylation at the tyrosine residues in  its cytoplasmic domain 
(Mohammadi et al.  1996;  Ellis et al.  1986;  Kendall et al.  1999;  Fantl,  Escobedo, 
and Williams 1989) as a consequence of oligomerisation of the protein, an event 
mediated  by  ligand  binding.  Autophosphorylation  of  the  activation  loop  in  the 
kinase  domain,  which  contains  between  one  and  three  tyrosine  residues, 
stimulates the kinase activity of the protein. This in turn acts by catalysing the y 
phosphate  of  adenosine  tri-phosphate  (ATP)  to  hydroxyl  groups  of  tyrosine 
residues  on  target  proteins  (Hunter  1998).  Autophosphorylation  of  the 
juxtamembrane  region,  kinase  insert  or  carboxy-terminal  domain  results  in  the 
creation of docking sites for phosphotyrosine recognising molecules.
The  mechanism  used  to  trigger  autophosphorylation  of  an  RTK  is 
oligomerisation  of  a  given  receptor  (Ullrich  and  Schlessinger  1990).  Ligand 
binding of the extracellular domain induces a structural rearrangement facilitating 
the autophosphorylation in the cytoplasmic domains.  For receptors such as RET 
which bind dimeric ligands, the dimeric receptor is the competent signalling form 
(Durick et al 1995) and this degree of oligermisation is probably sufficient in most 
instances.  Other  RTKs  may  require  further  steps  for  signalling  to  occur.  For 
example,  a  dimeric  ephrin  is  insufficient  to  initiate  the  complete  range  of 
responses that arise from a  tetrameric ephrin (Stein et al.  1998).
341.4.1.2 RET
The  Rearranged  during  transfection  (RET)  proto-oncogene  encodes  one 
such receptor tyrosine kinase (Takahashi,  Ritz,  and Cooper 1985). The genomic 
sequence of RET in humans is approximately 55KB, containing 20 exons (Pasini 
et al.  1995) at position  10q11.2 (Ishizaka et al.  1989).  Homologues of RET have 
been  found  in  vertebrates  and  invertebrates  including  Drosophila melanogaster 
(Hahn  and  Bishop  2001).  Alternative  splicing  of this  sequence  generates three 
isoforms of RET named for the number of residues at the C-terminal end of the 
protein;  RET9,  RET43  and  RET51  (Tahira  et  al.  1990;  Myers  et  al.  1995).  All 
three isoforms  undergo transcription,  but mRNA expression  of RET43  is sparse 
and  its sequence is less well conserved  between species than that of its’ sibling 
isoforms (Myers et al.  1995).  Furthermore, RET43 protein has not been shown to 
be transcribed in cells. The amino acids in these c-terminal tails differ not only in 
their number but also their sequence. The number of tyrosine residues within the 
isoforms  also  varies.  RET9  contains  the  sixteen  tyrosines  positioned  in  the 
nonvariable domains and  RET51  contains an additional two within  its 51  amino- 
acid tail (Myers et al. 1995).
The extracellular structure of RET contains four serial  cadherin-like  motif 
repeats  and  a  cysteine  rich  domain  (Iwamoto  et  al.  1993).  Cadherins  are  Ca2+ 
dependent cell-cell  adhesion  molecules  utilising tandemly repeated extracellular 
domains to  effect this  adhesion.  Calcium  binding  to these  cadherin  domains  is 
believed to  protect the  molecule from degradation  by  inducing  linearisation  and 
increased rigidity of the extracellular domain (Nagar et al  1996).  It is also thought
35that this  process  aids  in  the dimerisation  of cadherins.  RET displays  properties 
which conform with these hypotheses; in the absence of calcium RET fails to fold 
properly within the endoplasmic reticulum (van Weering et al.  1998), while in the 
presence of calcium  it is  resistant to trypsin  activity (Takahashi et al.  1993)  and 
its  dimerisation  upon  ligand  binding  is  dependent  upon  calcium  (Nozaki  et  al. 
1998).
RET can  be activated by the binding of four known  molecules structurally 
related  to  the  TGF-p  superfamily,  namely  glial  cell  line-derived  neurotrophic 
factor (GDNF),  neurturin (NTRN), artemin (ARTN) and persephin.(PSPN). These 
secreted  molecules  possess  activity  in  a  variety  of  tissues  (Ibanez  1998; 
Kotzbauer et al.  1996;  Milbrandt et al.  1998; Baloh et al. 2000;  Baloh et al.  1997; 
Creedon  et  al.  1997).  Binding  of  these  ligands  is  mediated  by  co-receptors 
collectively  known  as  GDNF  family  receptor  a  (GFRa).  GFRas  are  glycosyl 
phosphatidylinositol-linked  (GPI-linked)  membrane  receptors.  Each  member  of 
the family specifically binds to one GDNF family ligand; GFRal  -  GDNF, GFRa2 
-  NRTN,  GFRa3 -  ARTN  and  GFRa4 -  PSPN. This specificity can break down 
in  vitro  with  GDNF  able  to  bind  GFRa2/3  and  ARTN  or  NRTN  able  to  bind 
GFRal  (Baloh et al.  1997;  Creedon et al.  1997; Jing et al.  1997;  Sanicola et al.
1997).  RET  cannot  bind  any  ligand  independently and  must  bind  a  complex of 
GFRa and GDNF family ligands (Airaksinen and Saarma 2002). The localisation 
of  RET  at  the  cell  membrane  may  be  dependent  upon  whether  it  binds  the 
membrane-bound or soluble form of GFRal  (Fig 1.7).
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Figure 1.7: Possible mechanisms of RET activation.
(A) GPI-linked, lipid raft bound, GFRal  dimers assemble with GDNF. RET is then 
recruited  inducing  dimerisation  and  autophosphorylation.  (B)  In  an  alternative 
view,  RET and GFRal  assemble as a pair of dimers at lipid rafts and bind GDNF 
secondarily which  stabilises the complex.  (C)  The  binding  of soluble  GFRal  by 
GDNF which then binds and allows transactivation of RET outside of the lipid raft. 
Localisation  of RET to the lipid  raft is then  induced  by binding  FRS2  (Fibroblast 
growth factor receptor substrate 2).
Taken from (Manie et al. 2001).
1.4.1.3  Conditions associated with defects in the RET pathway
RET has been linked to both the congenital defect Hirschsprung’s disease 
(HSCR) and multiple endocrine neoplasia type 2 (MEN2). MEN2, is characterised 
by medullary thyroid carcinoma and  is caused  by activation of the RET receptor 
(Borrello et al.  1995).
RET linked  HSCR accounts for over 50% of observed familial cases (Attie 
et al.  1995).  RET mutations display incomplete penetrance, the figures for which 
are significantly higher for males (72%) than females (51%).  RET mutations also 
contribute to greater than 33% of sporadic cases.  RET mutations have also been
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37associated  with  the  most  severe  forms  of  HSCR,  total  intestinal  aganglionosis 
(Seri et al.  1997).
The  phenotypes  of MEN2  and  HSCR could  be  interpreted  at first glance 
as  the  products  of  separate  mutations  displaying  as  they  do  opposing 
characteristics.  MEN2  results  from  over  proliferation  or  insufficient  cell  death 
whereas  HSCR  is  due  to  inadequate  proliferation/survival  or  inappropriate  cell 
death.  However, cases of MEN2 have been reported to co-segregate with HSCR 
(Decker and Peacock 1998; Decker, Peacock, and Watson 1998).
1.4.1.4  RET pathway mutants
Mouse  mutants  of  RET,  GDNF  and  GFRal  have  been  generated  to 
further  investigate  the  RET  signalling  pathway.  Non-isoform  specific  RET 
knockouts  display  aganglionosis  of  the  entire  intestine  accompanied  by  renal 
dysplasia (Schuchardt et al.  1994). The ENS of the oesophagus and stomach are 
only partially affected  (Durbec et al.  1996b; Yan et al.  2004).  It should  be noted 
that only homozygous  knockout mice develop this  phenotype,  unlike  humans  in 
which  a  single  null  mutation  can  be  sufficient  to  result  in  HSCR.  Also  renal 
dysplasia  is  extremely  rare  in  HSCR  cases.  More detailed  investigation  of RET 
signalling  has  involved the targeted  knockout of the  RET9 and  RET51  isoforms 
thus  generating  mono-isoformic  (mi)  RET9  and  RET51  mice  (de  Graaff  et  al. 
2001).  In  these  isoforms  miRET9  has  only  RET9,  whereas  miRET51  has  only 
RET51.  RET43  was  not  included  in  this  work  due  to  its  lower  sequence 
conservation  between  species  and  the  lack  of  proven  protein  expression. 
miRET9  mice  display  no  obvious  change  from  their  wild-type  counterparts’enteric  phenotype,  suggesting  no  role  for  the  RET51  isoform  in  ENS  cell 
guidance  or survival.  The  miRET51  mice  display  aganglionosis  of the  colon,  a 
phenotype more HSCR-like than that observed in non-isoform specific knockouts 
of  RET  in  mice,  indicating  that  the  RET9  isoform  is  required  for  normal  ENS 
development  (de  Graaff et al.  2001).  The  miRET51  mouse  model  provides the 
most accurate model of HSCR available in mice.
GDNF deficient mice display intestinal aganglionosis and kidney agenesis 
(Moore  et  al.  1996;  Pichel  et  al.  1996;  Sanchez  et  al.  1996)  similar  to  RET 
deficient mice, whereas mice lacking GFRal  have aganglionosis of the small and 
large  intestines  (Enomoto  et  al.  1998;  Cacalano  et  al.  1998).  Both  RET  and 
GDNF  null  mice  have  defects  in  their  dorsal  root  and  sympathetic  ganglia. 
GFRal  null mice do not exhibit this phenotype (Tomac et al. 2000).
Gene  knockdown  studies  in zebrafish  have also contributed  substantially 
to our understanding of the effects of absence of GFRal  in the developing  ENS 
(Shepherd  et  al.  2004).  Zebrafish,  unlike  birds  and  mammals,  possess  two 
orthologs  for  GFRal;  GFRal a  and  GFRal b  (Shepherd,  Beattie,  and  Raible 
2001).  The expression of both these forms,  and  GFRa2,  have been  inhibited  in 
zebrafish  using  morpholinos,  (short sequences of RNA designed  to bind to and 
inhibit  specific  mRNAs).  Treatment  with  GFRal a  morpholinos  resulted  in  a 
reduced number of enteric neurons particularly in the distal gut. Co-injection with 
the GFRal b  morpholino  led  to a total  lack of enteric neurons.  Embryos treated 
with  GFRal b  or  GFRa2  morpholinos  alone  displayed  no  enteric  phenotype;
39GFRa2  did  not  modify  the  affects  of  GFRala/b  when  co-injected,  and  is 
therefore  not  directly  involved  in  this  pathway.  These  studies  highlight  the 
essential  requirement of GFRal  for normal development of the enteric nervous 
system,  with  some  degree  of  redundancy  present  between  the  GFRal a  and 
GFRal b forms in zebrafish.
1.4.1.5 Downstream targets of RET
RET-ligand  binding  is  likely  to  result  in  the  two  halves  of  the  RET 
homodimer coming close enough to each other for trans-autophosphorylation to 
occur.  Four of the eighteen tyrosine residues in  RET51  become docking sites for 
proteins  with  specific  interaction  molecules  (Liu  et  al.  1996).  GDNF-dependent 
signalling  induces  activation  of the phosphatidylinositol  3-kinase  (PI3K)  and the 
mitogen-activated protein kinase (MAPK) pathways. The MAPK pathway requires 
the activation of the extracellular-regulated kinases (ERKs), c-Jun amino-terminal 
protein  kinases  (JNKs),  p38  MAPK  and  the  big  MAP  Kinase  (BMK1)  ERK5 
(Encinas  et  al.  2001;  Hayashi  et al.  2001;  van  Weering  and  Bos  1998;  Jhiang 
2000;  Hansford and Mulligan 2000).  RET can also activate Rho family GTPases 
including  Rho,  Rac and Cdc42 which alter the actin cytoskeleton involved  in cell 
motility  and  neurite  outgrowth  (Murakami  et  al.  1999;  Fukuda,  Kiuchi,  and 
Takahashi 2002). (Fig 1.8)
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Figure 1.8: Downstream targets of RET.
Activation  of  RET  results  in  autophosphorylation  (P)  of tyrosine  residues  in  the 
cytoplasmic domain. This provides docking sites for signalling partners as shown 
by solid linkers. In addition to these c-Src is thought to interact directly through an 
unknown site.
Cad - cadherin domain, Cys -  cystine rich domain, Tk -  tyrosine kinase domain. 
Y-(number  indicating  residue  position)  Y-1096  is  only  present  in  the  RET51 
isoform.
Taken from Manie et al (2001).
411.4.1.6 GDNF as a ligand for RET
The first ligand  identified for RET was GDNF,  reported  in  1993 (Lin et al. 
1993)  and  associated  with  RET  three  years  later  (Salomon  et  al.  1996).  The 
GDNF gene encodes a 211  amino-acid protein which is processed to form a  134 
amino-acid  secreted  form  that  exists  as  a  homodimer  (Lin  et  al.  1993).  As 
previously stated,  some degree  of crosstalk  has  been  reported  between  GDNF 
and  NTRN  via the GFRal  co-receptor in vitro (Creedon et al.  1997),  and  can  in 
turn  crosstalk  with  the  GFRa2  and  GFRa3  co-receptors  normally  dedicated  to 
NTRN  and ARTN  signalling  respectively (Jing  et al.  1997;  Sanicola  et al.  1997) 
(Fig 1.9).
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Figure 1.9: Interactions between RET/GDNF family ligands/GFRa co-receptors: 
Modified from Sariola and Saarma (2003).
42GDNF was initially identified  as a neurotrophic factor (Lin et al.  1993) but 
has since been linked to processes including cell proliferation, migration, survival 
and  differentiation  (Chalazonitis  et  al.  1998a;  Hearn,  Murphy,  and  Newgreen 
1998;  Heuckeroth et al.  1998; Taraviras et al.  1999; Worley et al. 2000; Young et 
al.  2001).  Activation  of  PI3K  appears  to  be  essential  for  many  responses  to 
GDNF-mediated  RET signalling.  Both  PI3K and  MAPK are involved  in migration 
and  neurite  outgrowth  but the  function  of  PI3K  cannot  be  compensated  for  by 
MAPK  (Natarajan  et al.  2002).  Cell  proliferation  depends  upon  PI3K activity as 
shown  by the  reduction  in  cell  proliferation observed  in  cells  cultured with  PI3K 
inhibitor  (Focke  et  al.  2001).  Differentiation  also  seems  dependent  upon  PI3K 
activity (Pong  et al.  1998).  The manner in which  the  PI3K or MAPK pathway is 
selected  is  unclear but  it has  been  suggested  that  RET found  in  lipid  rafts  may 
favour MAPK whereas  RET not associated with these  rafts would activate other 
pathways (Encinas et al.  2001). This lipid  raft localisation  may depend  upon the 
form of GFRal  involved in the GDNF-RET binding. GPI-linked GFRal  is thought 
to  assemble  the  RET-GFRa1-GDNF  complex  in  lipid  rafts  whereas  soluble 
GFRal  allows  assembly  outside  of  this  environment  (Tansey  et  al.  2000; 
Paratcha  et  al.  2001).  GDNF  signalling  has  also  been  shown  to  require 
glycosaminoglycans  (Barnett  et  al.  2002),  specifically  heparan  sulphate 
glycosaminoglycan.  A  model  in  which  heparan  sulphate  proteoglycans 
concentrate  locally at the plasma membrane is supported  by findings that show 
GDNF  activates  RET  even  in  cells  depleted  of  surface  heparin  sulphates,  if 
GDNF is found in high enough concentrations (Barnett et al. 2002).
431.4.1.7 GFRal  is a co-receptor for GDNF
The  GFRal  gene  is  located  at  position  10q26  (Eng  et  al.  1998; 
Gorodinsky et al.  1997) in humans and a region of chromosome19 in mouse with 
high homology to human  10q24-26 (Puliti et al.  1997). The human gene contains 
9  exons  (Eng  et  al.  1998)  which  undergo  alternative  splicing  (Shefelbine  et  al.
1998)  to  form  both  the  GPI-linked  and  soluble  forms.  GPI-linked  GFRal  is 
recruited  to the  plasma  membrane  by TGF-p.  In  the  absence  of TGF-p,  GDNF 
signalling  is  only viable  if soluble  GFRal  is  available  (Peterziel,  Unsicker,  and 
Krieglstein 2002). As mentioned  above,  GFRal  is a  high  affinity co-receptor for 
GDNF  although  it  may  also  bind  other  GDNF  family  ligands  (Sanicola  et  al.
1997).  In  addition  to  acting  as  the  high  affinity  co-receptor  for  GDNF  in  RET 
dependent  signalling  (Airaksinen  and  Saarma  2002),  GFRal  binds  GDNF  in 
signalling which is independent of RET (Popsueva et al. 2003;  Pezeshki, Franke, 
and Engele 2001).
1.4.1.8 RET expression in the ENS
RET  expression  is  first  detected  in  the  mouse  at  E8.5  in  the 
undifferentiated  neuroepithelium  of  the  neural  tube  (Pachnis,  Mankoo,  and 
Costantini 1993). The cells positive for RET at this time appear to be neural crest 
cells  emigrating  from  rhombomere  four.  No  other  emerging  neural  crest  cell 
populations  express  RET  at  this  stage.  The  first  RET  expression  observed  in
44enteric precursors appears at E9.0-9.5 in the mesenchyme of the third and fourth 
branchial  arches  through  which  the  neural  crest  are  known  to  migrate.  Twelve 
hours  later,  RET-positive streams of cells migrate from these areas towards the 
foregut.  At  subsequent time  points  the  RET-positive  cells  are  migrating  further 
down  the  gut  until  at  E14.5  the  entire  myenteric  plexus  has  been  colonised 
(Kapur,  Yost,  and  Palmiter  1992;  Young  et  al.  1998).  Although  no  secondary 
marker was  used  in  these  experiments,  results  would  appear to  be  consistent 
with RET marking the majority of migrating and postmigratory cells of the ENS in 
the mouse.
The earliest reports of positive RET expression in the chick were at HH5 in 
the primitive streak and  Henson’s  node (Robertson  and  Mason  1995).  At HH10 
the region of the neural tube from the level of somite seven up to the boundary of 
rhombomeres  five  and  six  was  positive  for  RET  expression  (Robertson  and 
Mason 1995). This presented as a gradient strongest at the rostral end. Stage 18 
embryos  were  reported  to  express  RET  in  pharyngeal  arches  one  to  four,  the 
region  surrounding  the  otic  vesicle  and  in  the  region  of the  developing  sacral 
crest.  E3.5 embryos retained  expression  in the structures seen  at stage  18 and 
RET positive cells were also found in the developing foregut (Homma et al. 2000; 
Schiltz, Benjamin, and Epstein 1999).
At  E4.5  RET-positive cells  had  migrated  down the gut to the  level  of the 
yolk  stalk  and  RET-positive  cells  were  present  in  the  caudal  nerve  of  Remak 
(Schiltz,  Benjamin,  and  Epstein  1999).  RET-positive cells  had  colonised the gut
to the  level  of the caecum  at  E5.5  in  which  high  levels  of RET were  observed.
45Between  E6  and  E7  vagal-derived  NCC  migrated  into  the  colon,  as  did 
projections from the nerve of Remak which was well formed  at E8. At this time, 
clusters  of  RET  positive  cells  were  present  along  the  entire  length  of the  gut 
connected by faintly stained protrusions.
In  the  experiments  of  Shiltz  et  al,  a  secondary  marker,  HNK-1,  was 
employed to assess RET expression through immunohistochemistry with respect 
to  the  entire  migrating  neural  crest  population  (Schiltz,  Benjamin,  and  Epstein
1999).  This approach  revealed that not all  neural crest cells were  RET positive. 
Initially a low percentage of HNK-1  positive cells were also positive for RET but 
this  number  increased  with  the  age  of the embryo.  In  order to  confirm  this  low 
level of RET protein,  in situ hybridisation was used to assess mRNA levels. This 
revealed  that  some  HNK-1  positive  cells  express  neither  the  RET  protein  or 
mRNA.  Most significantly of all, the cells at the wavefront of colonisation did  not 
appear to express RET, in contrast to the expected result in which RET would be 
present  at  the  wavefront  to  respond  to  the  chemo-attractive  effect  of  GDNF, 
which is expressed in the gut mesenchyme (Natarajan et al. 2002). Data from our 
laboratory relating to both the vagal and sacral populations of migrating crest has 
also  revealed  an  absence of RET from the wavefront cells  (Delalande,  Cooper, 
and Burns 2003).
461.4.2 Endothelin-3 Pathway
1.4.2.1  Endothelin-3
Endothelin-3  (ET-3)  is  a  member  of the  endothelin  group  of vasoactive 
peptides that consists of three members; Endothelin 1, 2 and 3. Endothelin 1  was 
cloned by Inoue et al  in  1989 and the sequences for two related  peptides,  ET-2 
and  ET-3,  were  isolated  from  genomic  fragments  (Inoue  et  al.  1989).  ET-3 
expression was later documented  in the hypothalamus (Bloch et al.  1989).  ET-3 
encodes a 230 amino-acid peptide precursor that includes ET-3 and a 15 amino- 
acid  precursor called  the  ET-3-like sequence.  The  ET-3  sequence  is  located  at 
position  20q13.2-q13.3  and  a  homologue  maps  to  chromosome  2  in  mouse 
(Bloch et al.  1989;  Malas,  Peters,  and Abbott  1994; Arinami  et al.  1991;  Malas, 
Peters,  and  Abbott  1994;  Arinami  et  al.  1991)  Once  cleaved  to  the  functional 
form  by  Endothelin  converting  enzyme  1   (ECE-1)  (see  below),  ET-3  acts  as  a 
soluble ligand for Endothelin Receptor B (EDNRB).
1.4.2.2 ECE-1
ECE-1  is responsible for the proteolytic cleavage of endothelins from their 
big  endothelin  form  to  the  biologically  active  peptide  (Schmidt  et  al.  1994). 
Located at position 1p36.1  (Matsuoka et al.  1996; Albertin et al.  1996) the ECE-1 
gene  encodes  a  predicted  770  base  open  reading  frame  which  undergoes 
alternative  splicing  to  form  two  variants  (Shimada  et  al.  1995;  Yorimitsu  et  al. 
1995).  ECE-linked HSCR cases have been reported (Hofstra et al.  1999) but are 
extremely rare.
471.4.2.3 Endothelin receptor B
There are two forms of endothelin  receptors,  selective (EDNRA -  specific 
to ET1) and non-selective (EDNRB) (Takayanagi et al.  1991). EDNRB encodes a 
442 amino-acid transmembrane receptor peptide which exhibits strong homology 
to rat sequences (Nakamuta et al.  1991).  In addition to these two forms, a splice 
variant of EDNRB named ETB-SVR, identical to EDNRB except at the C-terminal 
domain,  has  been  shown  to  be  expressed  as  mRNA  in  the  lungs,  kidney  and 
skeletal tissue (Elshourbagy et al.  1996).
1.4.2.4  Endothelin pathway diseases and Mutants
ET-3 homozygous null mouse mutants display Waardenburg-Hirschsprung 
like symptoms, with enteric and pigmental defects (Baynash et al.  1994; Kunieda 
et al.  1996;  Gariepy,  Cass,  and  Yanagisawa  1996).  ET-3'/_  animals die within  a 
few weeks of birth. These observations in mice were supported by demonstrating 
a  homozygous  substitution/deletion  of  ET-3  in  one  Waardenburg-Shah  patient 
(Edery  et  al.  1996)  and  a  mis-sense  mutation  observed  in  a  second  patient 
around  the  same time  (Hofstra  et al.  1996).  The  affected  region  of gut  in  ET-3 
knockout  mice  lies  between  the terminal  hindgut  and  the  caecum.  It  has  been 
shown  that  ET-3  inhibits  the  differentiation  of  NCCs  into  neurons  through 
interactions with  its receptor EDNRB in vitro (Wu et al.  1999). This process may 
act to balance the effects of GDNF-induced differentiation and proliferation.
48Additionally,  in  lethal  spotted  mice  (Is/Is),  a  spontaneously occurring  null 
mutation in  ET-3, an abnormal arrangement of the extracellular matrix is seen in 
the  caecal  region,  the  caudal  limit  to  successful  vagal  neural  crest  cell 
colonisation in these animals.  In addition the enteric smooth muscle of Is/Is mice 
displays a developmental delay (Rothman,  Goldowitz,  and  Gershon  1993).  One 
effect  of  this  delay  is  an  accumulation  of  laminin-1  by  the  cells  destined  to 
become smooth muscle (Rothman et al.  1996). Vagal neural crest cells express a 
laminin-1  receptor  upon  entering  the  foregut.  Laminin-1  promotes  the 
differentiation of neural crest cells into a neuronal phenotype, thus in combination 
with  the  increased  differentiation  already occurring  due to the  lack of ET-3,  the 
pool of neural crest cells is insufficient to allow complete gut colonisation.  Neural 
crest cells competent for ET-3 are incapable of migrating through explants of Is/Is 
terminal  gut  grown  in  culture,  and  Is/Is  neural  crest  cells  successfully  pass 
through  corresponding  wildtype  hindgut,  indicating  that  the  mesenchyme 
environment is the cause of the failure in colonisation (Rothman,  Goldowitz,  and 
Gershon  1993).  Additionally  ectopic  pelvic  ganglia  are  present  in  Is/Is  mice 
suggesting  that  the  sacral  crest  fails  to  reach  the  hindgut  due  to  premature 
differentiation during migration.
EDNRB  mouse  mutants exist  in  the form  of the  spontaneously occurring 
piebald  lethal  mutant  (Ednrbs l)  and  the  engineered  knockout  Ednrbtm 1Y w a 
(Hosoda et al.  1994).  The  Ednrbs l mouse results from  a  1cM  deletion  about the 
EDNRB  locus (Roix et al.  2001) whereas the  Ednrbtm 1Y w a strain was specifically 
engineered  via  replacement  of  a  4.2kb  exon  3  containing  fragment  with  a 
neomycin selective cassette. Both these strains have aganglionosis; however the
49phenotype exhibited by the generated knockout when crossed with the Sox10D o m  
is  more  severe  than  that  of  the  naturally  occurring  mutation  under  the  same 
conditions (Cantrell et al. 2004). This may indicate that the genetic background of 
the  piebald  lethal  strain  has  undergone  some  selection  for  aganglionosis 
suppression.
EDNRB  is  normally  expressed  in  enteric  ganglia  and  the  surrounding 
mesenchyme  of the  gut  (Wu  et al.  1999).  This  expression  can  be disrupted  by 
failures  in  the  Sox10/Pax3  transcription  factors.  For  example,  in  splotch  mice 
(Pax3'A )  there  is  an  absence  of  EDNRB  expression  in  the  enteric  ganglia 
although it is retained by the mesenchyme (Lang et al. 2000a).
501.4.3 Sox genes
1.4.3.1 Sox genes
Sox genes were discovered in the early 1990s as a family of genes related 
to the testis determining factor gene Sry found in mammals (Gubbay et al.  1990). 
Since then  homology  based  screening  has  added  many  more  members to this 
group  (Denny et al.  1992; Wright,  Snopek,  and  Koopman  1993;  Cremazy et al.
1998),  with  twenty  Sox  genes  having  been  identified  in  mouse  and  human 
(Schepers,  Teasdale,  and  Koopman  2002).  From  these  twenty  genes,  eight 
groups  can  be  discerned  based  upon  intron-exon  structure  and  sequence.  Sox 
genes contain the HMG (high mobility group) domain, alongside the TCF,  MATA 
and HMG/UBF families (Laudet, Stehelin, and Clevers 1993; Soullier et al.  1999), 
which comprises a 79 amino-acid  DNA binding domain  (Gubbay et al.  1990). All 
HMG domain sequences appear highly conserved and are capable of binding the 
sequence AACAA(A/T)G (Wegner 1999).
1.4.3.2 Sox10
Sox10 is a member of the Sox family of transcription factors (group E) that 
has  been  linked  to the  neurocristopathy Waardenburg  syndrome  (Bondurand  et 
al.  1999) and Waardenburg-HSCR (Pingault et al.  1998).  Its sequence  is  highly 
conserved  between  human  and  mouse  (Pusch  et al.  1998)  and  encodes  a 466 
amino-acid  peptide.  The  human  gene  has  been  mapped  to  position  22q12-q13 
(Pingault et al.  1997). Sequence analysis indicates a common evolutionary origin
51between  Sox10  and  Sox9,  another  member of the  Sox family  also  involved  in 
regulation of neural crest development (Cheung and Briscoe 2003).
Sox10  is  expressed  in  neural  crest  cells  but  is  subsequently  down- 
regulated  in all non-glial progeny (Kim et al. 2003;  Paratore et al. 2002;  Paratore 
et al. 2001).  Both the gliogenic and neurogenic potential of neural crest cells are 
maintained by Sox10.  Furthermore, forced expression of Sox10 inhibits neuronal 
differentiation  (McKeown et al. 2005).  In the absence of functional Sox10 neural 
crest  derived-structures  are  present  and  initial  neural  crest  formation  appears 
normal  (Southard-Smith,  Kos,  and  Pavan  1998;  Herbarth  et al.  1998;  Britsch  et 
al.  2001).  It  can  thus  be  deduced  that  Sox10  is  not  required  for  the  initial 
specification of a neural crest fate,  nor in the initial  migration of these cells. The 
cells which would normally express Sox10 undergo apoptosis prior to maturing in 
Sox10'/_  embryos  (Southard-Smith,  Kos,  and  Pavan  1998;  Paratore et al.  2002; 
Kapur 1999).
1.4.3.3  SOX10 mutant models
The  dominant  megacolon  (Dorn)  mouse  model  of  HSCR  arose 
spontaneously  at  the  Jackson  Laboratory  (Lane  and  Liu  1984).  Heterozygotes 
exhibit  white  pigment  spotting  and  deficiencies  in  the  number  of  myenteric 
ganglia  at  the  level  of  the  colon;  homozygous  mice  die  within  two  weeks  of 
gestation.  Sox10  was  identified  as  the  gene  underlying  the  Dorn  (HSCR) 
mutation  by  positional  cloning  (Southard-Smith,  Kos,  and  Pavan  1998).  It was 
demonstrated that in these mice there is disrupted expression of both Sox10 and
52EDNRB  and  a  loss  of  neural  crest  derivatives  via  apoptosis  (Southard-Smith, 
Kos,  and  Pavan  1998).  This  body  of work,  and  that  of others  (Herbarth  et  al.
1998), shows that Sox10 is essential for peripheral nervous system development.
More recently a LacZ knock-in of Sox10 was engineered into mice (Britsch 
et al. 2001). These animals show similar deficiencies to the Dorn mice.  However, 
the  LacZ  mice  are  null  mutants,  unlike the  Dorn  mutation,  which  may  possess 
dominant properties (Potterf et al. 2000).
1.4.3.4  SOX8 acts as a modifier of SOX10 induced enteric defects.
Sox8  is another member of the Sox family of transcription factors  (group 
E) that is associated with  HSCR.  Located  at position  16p13.3  it encodes a 446 
amino acid sequence with 47% homology to Sox9 and Sox10.
Sox8'/_  mice develop  normally in  utero,  are viable and  born  at Mendelian 
ratios (Sock et al. 2001). These mice do, however, display a significant reduction 
in weight that may arise from metabolic deficiencies. The functional redundancies 
of group  E Sox proteins (Sox9,  Sox10)  may explain the mild  phenotype seen  in 
these  knockout  mice.  Despite  the  knockout  of  Sox8  having  no  effect  on  the 
enteric  nervous  system,  Sox8  has  been  shown  to  act  as  a  modifier of Sox10- 
induced HSCR. As described above, mice homozygous null for Sox10 die before 
or at  birth  but  heterozygotes  are  born  at  Mendelian  ratios  with  20%  displaying 
HSCR-like  aganglionosis.  Using  LacZ  knock-ins  of  both  the  Sox8  and  Sox10 
genes,  it was  shown  that  Sox8  increases the  severity of the  Sox10  phenotype
53resulting in increased mortality of Sox8lacZ/lacZSox10+/LacZ and Sox8+/lacZSox10+/LacZ 
mice prior to birth (Maka,  Stolt, and Wegner 2005). Additionally, the loss of even 
one  copy  of  Sox8  dramatically  increases  the  Sox10+/LacZ  ENS  phenotype.  In 
these  mice  the  aganglionic  region  extended  rostral  of the  caecum  for  varying 
lengths into the small intestine.
1.4.3.5  SOX10 as a modulator of RET
Sox10  displays  a  weak,  but  reproducible,  activity  as  a  transcriptional 
activator  in  humans  (Kuhlbrodt  et  al.  1998b;  Kuhlbrodt  et  al.  1998a).  The  C- 
terminus  contains  a  transactivation  domain,  and  the  N-terminus  contains  the 
synergistic enhancer of other transcription factors. Sox10 acts synergistically with 
Pax3 to modulate the expression of target genes (Lang et al.  2000b).  Pax3  is a 
member of the paired-box-containing transcription factors (Goulding et al.  1991), 
and  mutations  in  Pax3  may  result  in  WS  but without  HSCR  (Tassabehji  et  al. 
1992).  However,  mice with  mutant Pax3 (Splotch) (Epstein et al.  1993)  possess 
defects  in  their  enteric  ganglia  (Lang  et  al.  2000a).  Pax3-WS  patients  are 
heterozygous for the  mutations as  homozygous  loss  is  lethal  (Ayme and  Philip 
1995).
Ret is one of the targets of the Sox10-Pax3 synergistic activation (Lang et 
al.  2000b).  Splotchembryos display reduced  RET expression which would,  as 
previously discussed,  account for reduced  enteric ganglia cell  numbers. To test 
the  ability  of  Pax3  and  Sox10 to  activate  Ret,  P19  cells  were  transfected  with 
Pax3,  Sox10  or  both  genes  to  assess the  relative  transcription  of Ret  in  these
54lines (Lang et al. 2000b). Sox10 alone does not result in a significant increase in 
RET  levels.  However,  Pax3  or  co-transfected  Sox10  and  Pax3  do  result  in 
significant increases.  By using deletion constructs of the Ret enhancer region,  a 
45bp  sequence  required  for  the  synergistic  activation  by  Pax3-Sox10  was 
located  which  contains  both  transcription  factor  binding  sequences.  The 
interaction  between  these  two  transcription  factors  is  a  physical  one. 
Immunoprecipitation  using  an  antibody  for  Sox10  was  also  able  to  precipitate 
Pax3  but  only  if  Sox10  was  present  in  the  reaction  (Lang  and  Epstein  2003). 
Deletion  mutants showed that the paired  domain  of Pax3 and the  HMG domain 
of Sox10 are required for the physical interaction of these two proteins.
1.4.3.6  SOX10 regulates EDNRB expression
As previously mentioned, mice and humans with mutations of the EDNRB 
gene develop  aganglionosis  of the  hindgut distal  to the  caecum  (Hosoda et al. 
1994;  Puffenberger et al.  1994).  Recent work extensively reviewed the effects of 
strain  background  on  the  SOX10D o m   mutant  mouse  (Cantrell  et  al.  2004).  The 
authors showed that the SOX10D o m  mutant phenotype differs in  penetrance and 
severity  between  the  B6.Sox10D o m   and  C3Fe.Sox10D o m   strains.  Using 
polymorphic  simple  tandem  repeats  it  was  shown  that  B6  EDNRB  haplotypes 
correlate with an  increased severity and penetrance of aganglionosis though not 
of hypoganglionosis.  Addressing  the  issue of gender,  male  heterozygotes were 
found  to  exhibit  closer  statistical  means  to  the  B6  homozgotes  whilst  female 
heterozygotes  displayed  statistical  means  closer  to  the  C3Fe  homozygotes, 
indicating a more severe phenotype in male heterozygotes compared to females.
55In  this  work  two  strains  of  EDNRB  deficient  mice  were  used.  The  naturally 
occurring and established  Ednrbs l strain which results from a  1cM deletion about 
the  EDNRB  locus  (Roix  et  al.  2001),  and  the  generated  knockout  Ednrbtm 1Y w a 
(Hosoda  et  al.  1994).  Interestingly  it  was  found  that  the  Ednrbtm 1Y w a  strain 
resulted  in a more severe phenotype than that seen  in Ednrbsl. This may be due 
to aganglionosis suppressing mutations having been bred into the Ednrbs l strain.
Deletion  studies  of the  region  upstream  of the  EDNRB  gene  identified  a 
1  kb enhancer region, between -1.2kb and -250bp of the start codon,  specific to 
ENS  phenotypes  (Zhu  et  al.  2004).  Binding  sites  for  the  transcription  factor 
SOX10  were  identified  within  this  region  and  mutational  studies  of these  sites 
indicate that SOX10 interacts directly with the EDNRB enhancer.
1.4.4  Mash-1
Mammalian  acheate-scute  homologue  1   (Mash-1)  is  a  basic  helix-loop- 
helix  transcription  factor,  the  human  version  of  which  (ASCL1)  is  located  at 
position 12q22-q23 (Renault et al.  1995) and is predicted to encode a 238 amino 
acid protein (Ball et al.  1993).  Mice homozygous for the null Mash-1  allele die at 
birth  due to  defects  in  respiration  and feeding.  Post-mortems  revealed  that the 
olfactory  epithelium  and  sympathetic,  parasympathetic  and  a  portion  of  the 
enteric  nervous  systems  were  affected  (Guillemot  et  al.  1993).  The  enteric 
nervous system  of the oesophagus was  most severely  affected  in  Mash’7 ' mice 
(Sang et al.  1999).  Inspection of the subclasses of enteric neurons revealed that
56transiently  catecholaminergic  (TC)  precursors,  which  give  rise  to  the  entire 
enteric population of serotonergic neurons, were absent.
1.4.5  Phox2B
Paired-like  homeobox  2b  (Phox2b),  a  protein  of  314  amino  acids 
(Yokoyama et al.  1996) located at position 4p12 (Amiel et al. 2003), is expressed 
in  all ganglia  of the autonomic nervous system  including the  ENS  (Pattyn  et al. 
1997).  Phox2B'/'  mice  generated  by  homologous  recombination  fail  to  correctly 
develop  autonomic  ganglia.  Although  Phox2B  mutations  are  most  commonly 
linked  to  congenital  central  hypoventilation  syndrome  (CCHS)  it  has  also  been 
associated with HSCR cases displaying a low level of penetrance (Benailly et al.
2003).
Phox2  genes  are  known  to  regulate  the  expression  of  Ret  in  the 
sympathetic and enteric nervous systems in mice, and are also necessary for the 
maintenance of Mash-1  expression.  It is possible that Phox2B acts as a modifier 
determining the penetrance of other HSCR associated  mutations  in genes such 
as RET, either as a result of point mutations effecting protein function or through 
haplo-insufficiency.  Haplo-insufficiency  of  Phox2B  could  result  in  reduced 
expression of RET predisposing towards HSCR.
571.4.6 SMADIP1
SMAD-interacting protein  1   (SMADIP1), also known as SIP1  or Zinc finger 
Homeobox  1B  (ZFHX1B),  is  a  member of the  delta-EF1/Zfh1  family zinc finger 
homeodomain  proteins  found  at  position  2q22  (Wakamatsu  et  al.  2001). 
SMADIP1  interacts  with  activated  full  length  receptor-mediated  SMADs  to  co­
repress expression of TGF-beta-controlled genes.
SMADIP1  has been  linked to cases of HSCR (short segment) associated 
with  microcephaly,  mental  retardation,  hypertelorism,  submucous  cleft  palate, 
and short stature. Amiel et al  (Amiel et al.  2001) found that 8 out of 19 patients 
suffering  HSCR  and  mental  retardation  possessed  SMADIP1  deletions  or 
truncations.  These  mutations,  in  addition  to  the  frameshift,  and  nonsense 
mutations described (Wakamatsu et al. 2001; Yamada et al. 2001; Cacheux et al. 
2001), suggest that the defects result from a haplo-insufficiency of the SMADIP1 
gene. Mice generated with a Zfhxlb mutation comparable to that found in human 
patients revealed that SMADIP1  knockouts do not develop postotic vagal neural 
crest  cells  (Van  de  Putte  et  al.  2003).  Thus  SMADIP1  is  essential  for  the 
formation of vagal neural crest cell populations.
1.4.7  BMP and Noggin
Bone  morphogenetic  proteins  (BMPs)  are  a  sub-group  of  secreted 
signalling  molecules of the TGF-P family. Activation  of BMP  receptors  results  in 
SMAD  phosphorylation  and  activation  of  the  subsequent  signalling  cascade
58(Zwijsen, Verschueren,  and  Huylebroeck 2003).  They have already been shown 
to be involved in neural crest cell migration (Sela-Donenfeld and  Kalcheim 2000; 
Sela-Donenfeld  and  Kalcheim  1999)  and  regulation  of regionalisation  of the gut 
(Faure et al. 2002;  Smith et al. 2000). Their role in the control of development of 
enteric precursors is currently unclear.
BMP-2  and  BMP-4  promote  the  differentiation  of enteric  precursors  into 
TrkC-expressing  Neurotrophin-3-dependent  neurons  (Chalazonitis  et  al.  2004). 
Overexpression  of  these  signalling  molecules  effectively  reduces  proliferation 
within  migrating  precursor  populations.  When  Noggin,  a  BMP  antagonist,  was 
expressed  in  the  developing  ENS  using  transgenic  mice,  the  total  number  of 
neurons was increased but at the expense of the TrkC subset (Chalazonitis et al.
2004).
Conflicting  data  have  arisen  in  another  recent  investigation  into  the 
expression  of  BMPs  in  the  developing  chick  ENS  (Goldstein  et  al.  2005).  This 
study revealed that suppressing the phosphorylation of SMAD by BMPs, though 
expression  of Noggin,  resulted  in a delay in the migration  of enteric precursors. 
Furthermore  enteric  ganglia  were  reported  as  being  reduced  in  size  and  the 
hindgut of experimental animals was hypoganglionic. The migration of these cells 
was delayed,  but not subsequent events such  as differentiation.  This delay was 
not  accompanied  by  apoptosis  of the  migrating  precursors.  To  test the  role  of 
BMPs in  ENS precursor migration collagen gel explants were performed.  These 
revealed  that  BMP4  alone  is  insufficient  to  promote  ENS  migration,  but  can
59modulate  the  effects  of  GDNF.  Noggin  significantly  inhibited  the  distance 
migrated by neural crest cells in these experiments.
1.4.8  NT-3 and TrkC
Neurotrophin-3  (NT-3) was  identified  as an  extension  to the  NGF,  BDNF 
family of neurotrophins through low stringency PCR (Jones and  Reichardt 1990) 
and  is  located  at  position  12p13  (Maisonpierre et al.  1991).  It  has  been  shown 
that  NT-3  induces  neural  crest-derived  cells  to  differentiate  into  neurons 
(Chalazonitis  et  al.  1994),  specifically  those  expressing  NADPH-diaphorase 
activity (Chalazonitis et al.  1998c) operating through the Trk-C receptor.
NT-3-deficient mice display severe defects in limb movement and die shortly after 
birth  (Ernfors  et  al.  1994).  These  defects  result  from  substantial  loss  of  the 
sensory peripheral nervous system, although motor neurons were not affected.  It 
has also been shown that disruption of the NT-3 gene results in cardiac defects 
consistent with failure of cardiac neural crest to migrate successfully (Donovan et 
al.  1996).  Recent  data  reveals  that  NT3'/_   mice  exhibit  a  delay  in  the  enteric 
innervation  of  the  oesophagus  by  two  days  during  development  (Reddy  and 
Kablar 2004).
601.5  Multiple pathways interact to successfully form a  functional enteric nervous 
system
The above pathways and most likely a significant number not yet reported, 
interact  and  contribute to  the formation  of a  functional  enteric  nervous  system. 
Complex interactions balancing cellular migration, differentiation and proliferation 
result  in  neural  crest  cells  migrating  successfully  from  the  vagal  and  sacral 
regions to the appropriate areas of gut mesenchyme. A general overview of the 
principal players in ENS formation is shown (Fig 1.10).
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Figure 1.10:
Complex interactions between multiple pathways control enteric precursor fate. 
Black linkers indicate fates as dictated by expression and interaction of proteins. 
Red arrows indicate modification of gene expression by transcription factors.
611.6 Aims
The  aims  of this thesis  are twofold  and  address  distinct questions  surrounding 
ENS formation. Whilst the spatiotemporal pattern of colonisation and migration of 
ENS  precursors,  enteric  smooth  muscle  and  intersticial  cells  of  Cajal  are  well 
documented  in  model  organisms  there  is  a  paucity  of  information  concerning 
early development in  Humans.  Using  immunohistochemistry to label these three 
cell  types  the  aim  is  to  fully  describe  the  development  of  a  normal  functional 
bowel between weeks 4 and 14 of embryonic development.
Secondly, the question  of RET’s ability to function  as a dependence  receptor in 
vivo  will  be  investigated  using  the  chick  as  a  model.  The  chick  allows  easy 
access for electroporation  and  enables  longterm  study  of the  effects.  By  using 
constructs designed to perturb the RET dependence receptor pathway the effect 
of  RET  dependent  apoptosis  on  cell  number  and  the  subsequent  ENS 
phenotypes will be investigated.
62Chapter 2: Materials and Methods
Details of solutions may be found on page 78.2.1  Human embryonic and foetal material
Tissue  for  this  research  was  obtained  from  two  sources,  the  Human 
Developmental Biology Resource (HDBR), located at the Institute of Child Health, 
University College London,  and funded by the Medical Research Council (MRC) 
and  Wellcome  Trust,  with  additional  material  from  the  Human  Tissue  Bank  at 
Hammersmith  Hospital,  London,  funded  by  the  MRC.  The  HDBR  provided  all 
samples  from  weeks  4-12,  with  older samples  up  to  week  14  provided  by the 
source at Hammersmith hospital.  Embryos were collected via surgical or medical 
termination of pregnancy (STOP/MTOP) and immediately transferred to the lab in 
ice  cold  DMEM.  Staging  was  carried  out according  to the  Carnegie  system.  In 
embryos  below seven  weeks  of gestational  age,  practical  dissection  of the gut 
was not possible, so these samples were processed as whole embryos. Embryos 
of  week  seven  and  older  had  their  gastrointestinal  tracts  dissected  free,  and 
pinned  out  in  a  Sylgard-coated  petri-dish  prior  to  fixation.  Embryos  recovered 
during the time course of this investigation were fixed in 4% PFA in PBS; in those 
which  had  been  retrieved  from  archives 4%  PFA fixation  had  been followed  by 
70%  ethanol  storage.  Post fixation,  tissue was  prepared  for wax embedding  or 
cryosectioning.  For  wax  embedding  samples  were  first  dehydrated  using  an 
alcohol  series  of increasing  concentration,  70%,  95%,  100%,  100%  (1x5mins), 
then cleared in histoclear (2x10mins). Samples were left in wax at 56°C overnight 
then embedded.  For cryosectioning tissue was cryoprotected  in  15% sucrose in 
PBS  overnight then  transferred  into gelatin  7.5%,  sucrose  15%  in  PBS.  Tissue
64was orientated during gelatin cooling in blocks and snap-frozen in liquid nitrogen- 
cooled isopentane at -60°C. Samples were stored at -20°C.
2.2 Sectioning
Transverse  sections  were  cut  from  whole  embryos  and  dissected  gut 
segments.  Sections were  obtained  at a thickness  of 6pm  from  wax  blocks  and 
10-14pm  from  frozen  blocks.  All  sections  were  placed  on  Superfrost  Plus 
microscope  slides.  Adjacent  sections  were  prepared  for  double  label 
immunohistochemical staining protocols.
2.3 Immunohistochemistry
Slides  were  initially  treated  to  remove  supporting  media.  Wax  sections 
were placed in Histoclear (3x5mins) then rehydrated through a descending series 
of alcohol (1x5min each) to PBS.  Frozen sections were incubated for 30 minutes 
in  PBS warmed to 37°C to remove the cryoprotectant.  Primary antibodies (Table 
2.1) were applied  overnight at 4°C  in  a  humid  box.  Slides were then washed  in 
PBS (3x5mins) and treated with appropriate secondary antibodies (Table 2.2) for 
one  hour  at  room  temperature.  Following  further  washing  in  PBS  (3x5mins) 
labelled  slides  were  visualized  either  with  the  fluorescent  marker  Alexa  488 
(Molecular  Probes  Inc),  or  Cy3  (Amersham  Pharmacia  Biotech),  or  with  the 
reaction  product  diaminobenzidine  (DAB)  (Sigma)  as  shown  in  Table  2.3.
65Following  DAB  staining,  sections were dehydrated through  an  ascending  series 
of alcohols (1x5min each),  cleared  in  Histoclear (2x5mins) and  mounted  in  DPX 
(Fisher Scientific). Fluorescent-labelled sections were mounted in Fluoromount-G 
(Southern Biotech).
Table 2.1: Primary antibodies used, source, species and dilution.
Primary Antibody Species Dilution Source
P 7 5 n ik Rabbit 1:250 Promega
c-kit Rabbit 1:100 DAKO
a-Smooth muscle actin Mouse 1:200 DAKO
PGP9.5 Mouse 1:100 Affiniti
QCPN Supernatant Mouse 1:3 U’ of Michigan
Table 2.2: Secondary antibodies used, source, species and dilution.
Secondary Antibody Dilution Source
Goat anti-rabbit IgG biotinylated 1:100 Southern Biotech
Rabbit anti-mouse IgG biotinylated 1:100 Southern Biotech
Table 2.3: Visualisation agents used, source, and dilution.
Visualisation Dilution Exposure Time Source
DAB 1:50 10-15 minutes Sigma
Streptavidin Cy3 1:400 30 minutes Amersham
Streptavidin Alexa 488 1:200 30 minutes Molecular Probes
Streptavidin-HRP 1:100 1hour Southern Biotech
66Images were  captured  on  a  Zeiss Axiophot  microscope  equipped  with  a 
Hamamatsu  C4742-95,  or  Leica  DC-500  digital  camera,  using  openlab  (v3.11) 
and  Firecam  (v1.20)  software  respectively.  Figures  were  assembled  and 
annotated in Adobe Photoshop.
Controls were performed for each experiment consisting of known positive 
control tissue and a negative control with no primary antibody applied.
2.4  Constructs
The  constructs  used  in  this work  were  produced  and  kindly  provided  by 
Servane Tauszig and Patrick Mehlen of the University of Lyon.
Table 2.4: Plasmids used in Chapter 4.
Construct Plasmid Promoter
PcDNA3 PcDNA3 None
RET9-ICD707N pJ70 CMV
RET9-ICwt pJ70 CMV
Caspase-9DN PcDNA3 CMV
672.5 DNA Preparation
Bacterial Transformation:
Competent cells (50pl of DH5a) were thawed on ice for 10-15mins before 
adding  1pl of the desired  plasmid and  leaving on  ice for a further 30 mins.  Cells 
were  subjected  to  a  heatshock  for  45  seconds  in  a  water  bath  set  to  42°C. 
Immediately after the  heatshock 950pl  of SOC  media  was  added  and  the  cells 
were placed in a shaker at 37°C for 1   hour. Ampicillin was added to pre-prepared 
bacterial  plates  (10cm  diameter):  40pl  Amp50  +  160pl  water  per  plate. 
Transfected bacteria were added to plates using aseptic conditions and placed in 
an oven at 37°C overnight to grow.
Plasmid preparation: Using Qiagen Midiprep kit. (Details of solutions on page 77) 
A single colony picked from a  recently transformed  plate,  or scrape from 
glycerol stock solution, was placed in 200ml LB broth with 200pl Amp50 at 37°C 
overnight in a shaker/incubator. The resulting cells were cold centrifuged in 50ml 
falcon tubes for 15mins at 6000xg.The supernatant was  removed  and the pellet 
resuspended  in  4ml  of  buffer  P1  (to  which  RNase  A  has  been  added)  by 
vortexing and/or pipetting up and down until no cell clumps remained. To this 4ml 
of buffer P2 was added and  mixed thoroughly but not violently and  incubated  at 
room  temperature  for 5  mins  maximum.  4ml  of P3  buffer was then  added  and 
again mixed thoroughly but not violently and incubated on ice for 15 mins.
68The  mixture  was  centrifuged  for  30mins  at  >20000  x  g  at  4°C,  the 
supernatant was  removed  and  respun  for  15  mins  under the  same  conditions. 
During  this  time  a  Qiagen-tip  was  equilibrated  with  4ml  of  Buffer  QBT.  The 
supernatant was  removed and  added to the equilibrated  Qiagen-tip, this passed 
into  the  resin  by  gravity  flow.  Washes  of  the  tip  with  2x10ml  of  Buffer  QC 
followed, and then the DNA was eluted with 5ml of Buffer QF, collecting the elute 
in a 10ml tube.
DNA  was  precipitated  by  adding  3ml  of  isopropanol,  mixing  and 
centrifuging at 15000 x g for 30 mins at 4°C. The supernatant was removed and 
the  DNA washed  in  70%  ethanol  (200pl/tube),  and  spun  for  a  further  15mins. 
After removing the ethanol the pellet was left to air-dry for 5 mins, the DNA was 
resuspended  in  50pl  H20   and  left  on  ice  for  15  mins.  Samples  were  then  run 
through a spectrophotometer to determine concentration and purity.
2.6  Microsurgical Procedures
Neural Tube ablations:
Chick eggs were obtained from Henry Stewart & Co.  Ltd and incubated in 
a humid forced-air incubator at 38°C. After positioning the egg on its side, 3ml of 
albumin was removed from the tapered end by syringe and discarded. A window 
was  then  cut  into  the  top  of the  egg  to  allow  access  to  the  embryonic  disc.  A 
solution  of equal  parts  Indian  ink  (Pelikan,  Fount  Indian  No. 17)  and  PBS  was 
injected under the embryo by mouth pipette to aid in visualisation. A flame-drawn 
Pasteur pipette forming a slender tip was used to inject the ink/PBS.
69Ablations of portions of the neural tube were performed on chick embryos 
at HH stage  10,  prior to neural crest cell migration. All microsurgical procedures 
were  performed  with  hand-crafted  needles.  A  standard  sewing  needle  was 
crudely  ground  down  by  bench  grinder  and  then  shaped  on  differing  grain 
Arkansas stones until a very fine cutting tip was obtained.
To gain access to the embryo an initial cut of the vitreous membrane was 
made.  A  small  drop  of  PBS  was  added  to  decrease  interference  by  surface 
tension. The first cuts to the embryo were made laterally through the neural tube 
between the seventh and eighth somites and just rostral to somite one.  Next the 
longitudinal  cuts  were  made  between  these  two  points,  cutting  between  the 
neural tube and the somites.
Once these four cuts had  been  made the neural tube from this area was 
removed. This requires further dissection to ensure the ventral midline has been 
properly  separated  from  the  remaining  embryo.  The  neural  tube  was  then 
removed  by  mouth  pipette.  The window of the  egg  was  then  sealed  with  clear 
adhesive tape and the egg was placed back in an incubator at 38°C.
2.7  Quail to chick neural tube grafts
The  quail  to  chick  interspecies  graft  is  an  extension  of  the  ablation 
protocol.  Essentially  a  chick  host  which  has  undergone  neural  tube  ablation 
receives a corresponding region of neural tube from a quail donor (isotopic graft).
70At HH  stage  10 the chick and  quail embryos are perfectly size matched for this 
procedure.  The  neural tube of the quail does  not require trimming  in width to fit 
the gap  left in the chick host,  and  if the ablation  is of a  high enough quality will 
seat itself snugly in place.
To  obtain  donor  quail  neural  tubes,  quail  eggs  at  stage  HH10  were 
removed  from  their shell  and  placed  into  a  dish  containing  PBS  at  a  depth  to 
cover  the  yolk.  The  embryonic  disc  was  dissected  from  the  yolk  using  fine 
dissecting scissors and  placed  in a Sylgard-coated  shallow dish filled with  PBS. 
The embryo was pinned out and the region of neural tube adjacent to somites  1- 
7 was crudely dissected free  using fine scissors.  The  neural tube and  attached 
somites was then transferred to another dish  containing  2%  pancreatin  (Sigma) 
in  PBS. After a  period  of approximately  10-15  mins the somites were dissected 
away  from  the  neural  tube.  Fine  mounted  needles  and  a  small  gauge  pipette 
were used to help gently remove the somites.  Using  a  mouth  pipette the neural 
tube was sucked up and down, the action of which removes the somites from the 
neural  tube  completely.  The  prepared  neural  tube  was  finally  transferred  to  a 
third  dish  containing  DMEM+10%FCS  and  placed  on  ice  until  ready  for 
transplantation.
After transferring the quail  neural tube to the  area  above the ablation  by 
mouth  pipette  a  dissecting  scalpel  was  used  to  fine  trim  the  length  of  the 
transplant tissue if required. The tissue was teased into place using any mark left 
to  identify dorsal-ventral  and  anterior-posterior orientation.  The  egg  was sealed 
with clear adhesive tape and returned gently to the incubator at 38°C.
712.8 Gene Electroporation
Electroporations  were  performed  with  a  BTX  ECM  830  square  wave 
porator (Genetronics Inc), PM 1000 cell micro-injector (Microdata Instruments Inc) 
and  5mm  gold  electrodes  (Harvard  apparatus  Inc).  Electrodes  and  injection 
needle  were  mounted  in  micromanipulators  (Narishige)  and  embryos  were 
visualized through a Zeiss Stemi SV11   stereomicroscope.
Electroporation settings for experiments involving one or both sides of the 
neural tube were; 20V,  5 pulses,  50ms pulse,  and  950ms pulse interval with the 
electrodes approximately 5-7mm apart and injection pressure of 10psi.  Injections 
were visualized  using fast green at concentrations around 2.5%.  Plasmids were 
mixed 50:50 (GFP: test construct). All DNA concentrations were at approximately 
2pg/pl prior to mixing.
Electroporations  were  carried  out  on  chick  embryos  between  HH8-10. 
Solutions of desired  constructs were  injected  into the  neural tube at the level of 
approximately the 4th  somite with the needle pointing towards the anterior end of 
the  embryo.  Electrodes  were  placed  at  the  level  of the  fourth  somite  with  the 
anode electrode  raised  slightly with  respect to the cathode. When  both sides of 
an embryo’s neural tube were electroporated, a second  injection was made and 
the  embryo  rotated  180  degrees  before  the  second  pulse  again  located  at the 
fourth somite.
72Screening  for successful  electroporations  was  done  on  a  LeicaMZ  FLIII 
stereomicroscope  using  the  Leica  IM1000  software  running  a  DC500  digital 
camera.  E2.5  embryos that  had  been  electroporated  on  one  side  of the  neural 
tube  were  then  dissected  and  placed  in  4%PFA  for  1.5  hours  before  being 
cryoprotected  overnight  at  4°C  in  sucrose  solution  (15%).  Samples  were  then 
placed  in  gelatin  for  cryosection.  Double  sided  electroporations  were  left  until 
E14.5  when  the  gut  was  dissected  along  its  full  length  and  placed  in  4%PFA 
overnight at 4°C for NADPH diaphorase staining.
2.9  3D reconstruction
Serial  transverse  sections  were  cut from  whole  embryos.  Sections  were 
obtained  at  a  thickness  of  15pm  from  frozen  blocks,  and  were  placed  on 
Superfrost  Plus  microscope  slides.  Sections  were  immunohistologically  stained 
and  mounted  (as  described  in  section  4.3)  prior  to  image  acquisition  (Leica 
DC500)  in  preparation  for  processing  as  a  digital  stack  required  for  3D 
reconstruction. 3D reconstruction was done using Improvision’s Volocity Software 
Version 3.
732.10  Whole-mount NADPH-diaphorase staining
Dissected  guts  were  stained  with  NADPH  diaphorase  after  fixing  with 
4%PFA overnight at 4°C. Guts were incubated in the dark at 37°C for 30 mins in 
a  solution  of  3ml  PBS  +  1.5mg  NBT  +  3mg  pNADPH  +  1.5pl  Triton  X-100. 
Samples were  visualised  under a  Leica  MZ  FLIII  stereoscope  to  assess  crude 
relative cell number. Further images were taken of lengths of gut which had been 
placed  under  raised  coverslips,  slightly  flattening  the  sample,  using  a  70% 
glycerol:  30%  PBS  mounting  media  and  visualised  under  a  Zeiss  Axioplan  2 
microscope.  Images  were  taken  using  a  Progres  3012  camera  from  Kontron 
Elektronik and compiled using Adobe Photoshop v.7.
2.11  TuneI  staining  (Terminal  deoxynucleotidyl  Transferase  Biotin-dUTP  Nick 
End Labelling)
Chick embryos were dissected at E1.5,  E2, and  E2.5 and fixed in 4%PFA 
for 1   hour at room temperature. They were then washed in PBS (2x5mins) before 
undergoing  ascending  serial  dehydration  in  methanol,  25%,  50%,  75%,  100% 
(x2), for 15mins each on ice.  If stored for later processing, embryos were kept in 
100% methanol at-20°C.
Embryos  were  rehydrated  in  10  minute  washes  of 75%,  50%,  and  25% 
MeOH/PBT (PBT = PBS + 0.1% Tween 20) at room temperature. They were then 
washed  in  PBT  (3x5mins)  and  incubated  in  lOpg/ml  proteinase  K/PBS at  room 
temperature for: - E1.5 -  3.5mins, E2/2.5 - 4mins. Next embryos were washed in
742mg/ml  glycine for 2mins to quench the  PK activity and  then further washed  in 
PBT (2x2mins).  Post fixation of tissue was carried  out using 4%PFA for 20mins 
at  room  temperature.  Embryos were washed  again  in  PBT  (5x5mins)  and  then 
fixed in pre-chilled ethanol : acetic acid (2:1) for 10 mins on ice.  Further washing 
was carried  out in  PBT (3x5mins)  before embryos were  incubated for 1   hour at 
room temperature  in  equilibrium  buffer (100-200pl).  As  much  buffer as  possible 
was  removed  from  the  tubes  without  risking  damage  to  embryos  before  TdT 
enzyme was added to cover the embryos and left overnight at 37°C.
After  washing  with  working  strength  stop  buffer  for  3  hours  at  37°C, 
changing the solution every hour, embryos were then washed  in  PBT (3x5mins) 
before being subject to blocking with 2mg/ml BSA, 5% sheep serum in PBT for at 
least  an  hour  at  room  temperature.  Next  embryos  were  incubated  in  antibody 
solution (1/2000 anti-dig Alkaline Phosphatase-conjugated Fab, 2mg/ml BSA,  1% 
sheep serum in PBT) for either 2 hours at room temperature, or overnight at 4°C.
If the antibody was left on for 2 hours, embryos were washed with 2mg/ml 
BSA/PBT  (2x10mins)  and  then  washed  overnight  at  4°C  agitating  in  a  large 
volume.  If the  antibody  had  been  left on  overnight  embryos  were  washed  with 
2mg/ml  BSA/PBT  (4x1 hour)  and  then  left  overnight  at 4°C  agitating  in  a  large 
volume.
The  next day embryos were washed  in fresh  NTMT at room temperature 
(3xmins),  and transferred to glass pots.  Placing  1ml  of freshly made  NTMT into
75each pot and adding  17pl of NBT/BCIP mix, embryos were incubated in the dark 
for  10-15mins  whilst  agitating.  They were  then  washed  in  PBT  (3x5mins),  and 
fixed  in 4%PFA for 30mins at room temperature,  before further washing  in  PBT 
(3x5mins).  To  store  embryos  for  later  photographing  they were  placed  in  PBT 
(1% Tween 20) with a drop of sodium azide at 4°C in the dark.
2.12  In situ Hybridisation
RNA probes were synthesised for RET and  Sox10 (Table 2.4)  using  DIG 
labelling.  1pl of linearised  probe was added to the synthesis solution  and  left at 
37°C  for  two  hours:  DEPC-H2O  (23.5pl),  5x  buffer  (8pl),  100pm  DTT  with 
polymerase(4pl),  DIG  RNA  labelling  mix  (2pl),  100u/pl  RNAsin  (0.5pl),  10u/pl 
RNA  polymerase  (1pl).  Meanwhile  a  2pl  aliquot  was  removed  and  run  on  1% 
agarose gel.  2pl  of DNase-1  was added for fifteen  minutes at 37°C.  Afterwards 
80pl  of  DEPC-H2O  was  added  and  the  RNA  precipitated  using  10pl  4M  LiCI, 
300pl  ethanol  for  twenty  minutes  on  ice.  RNA  was  then  spun  for  15  mins  at 
15000rpm  and washed  in 70% ethanol and allowed to air-dry. After redissolving 
in  120pl  DEPC-H20  this  precipitation  step  was  repeated.  Finally  RNA  was 
resuspended in DEPC-H20 to 0.1pg/pl and stored at -20°C.
For wholemount in situs embryos were collected at daily intervals between 
E1.5  and  E4.5.  Embryos  aged  E4.5  underwent  dissection  to  remove  the  gut, 
whereas  earlier  stages  were  processed  intact.  After  dissection  samples  were
76fixed in 4%PFA/PBS overnight at 4°C.  If continuing at a later date fixed embryos 
could then be stored at 4°C in 1% PFA/PBS for several weeks.
Samples were washed in  PBT twice for five minutes then dehydrated  in a 
methanol/PBT  series,  25,  50,  75,  and  100%  methanol  for  five  minutes  each. 
Embryos  were  washed  in  6%H202/Me0H  for  one  hour  then  methanol  for  five 
minutes. Samples were stored in methanol overnight at 20°C.
Table 2.5: In situ probe sources and detection methods.
Probe Source Detection Source
RET Vassilis Pachnis* Anti-dig AP Roche
Sox 10 Paul Scotting** Anti-dig AP Roche
* National Institute of Medical Research  ** University of Nottingham
Samples  were  rehydrated  in  a  methanol/PBT  series,  75,  50,  and  25% 
Methanol, for five minutes each and then two five minute washes of PBT. Three 
twenty minute detergent wash  steps followed this and then samples were left in 
4%PFA/PBT  for  a  further  twenty  minutes.  They  were  then  rinsed  in  PBT  and 
washed a further two times for five minutes each.  Further rinsing in an equal part 
solution  of  prehybridisation  mix  and  PBT,  at  room  temperature  and  at  70°C, 
preceded  a  wash  of  at  least  one  hour  in  a  70°C  waterbath  with  prewarmed 
prehybridisation  mix.  This  was  exchanged  for  prewarmed  hybridisation  mix 
(prehybridisation mix plus probe) and left overnight at 70°C in the water bath.
77On the third  day,  four 30  min  prewarmed  solution  X washes followed  an 
initial rinse at 70°C.  Samples were washed in equal parts Maelic acid buffer with 
tween  (MABT)/Solution  X  for  a  maximum  of ten  minutes  at  room  temperature 
then  rinsed  in  MABT three times and washed  in  MABT for thirty minutes twice. 
An  hour  in  2%  Boehringers  blocking  reagent  (BBR)/MABT  followed  at  room 
temperature, then  between  one and two hours in  20%  Serum/ 2%  BBR/ MABT. 
Finally embryos were  left shaking  overnight  at 4°C  in  a  solution  of 20%  sheep 
serum/ 2% BBR/ MABT plus anti-Dig antibody (1:2000).
The  next day,  after three  MABT  rinses,  at  least seven  MABT washes  of 
one  hour  were  performed  at  room  temperature.  Samples  underwent  one  last 
change of MABT and were left shaking overnight at room temperature.
The final step developed the staining.  Four NTMT washes of ten minutes 
preceded  the  colour  reaction  step.  This  consisted  of  12pl  of  NBT/BCIP  stock 
solution being added to 2ml of NTMT and samples were left shaking on ice in the 
dark until the colour reaction developed.  If the staining solution became purple it 
was replaced and the reaction continued. A ten minute NTMT wash cleaned the 
samples  and  then  background  was  reduced  through  an  initial  ten  minute  PBT 
wash followed by an overnight wash when required. Samples were stored in PBT 
plus a drop of sodium azide at 4°C in the dark.
782.13 Solutions
Buffer P1: resuspension Buffer
50mM Tris-CL pH 8,  10mM EDTA,  100pg/ml Rnase A
Buffer P2: Lysis Buffer
200mM NaOH,  1% SDS (w/v)
Buffer P3: Neutralisation Buffer
3M potassium acetate pH 5
Buffer QBT: Equilibration Buffer
750mM  NaCI,  50mM  MOPS  pH7,  15%  isopropanol  (v/v),  0.15%
Triton x-100 (v/v)
Buffer QC: Wash Buffer
1M NaCI, 50mM MOPS pH 7,  15% Isopropanol (v/v)
Buffer QF: Elution Buffer
1.6M NaCI, 50mM Tris-CI pH 8.5,  15% isopropanol (v/v)
79Modified Carnov’s fixative:
Ethanol 60%
37% Formaldehyde 30%
Acetic acid 10%
PBT:
0.1% Tween-20 in PBS (1ml in 11).
6% H?Cb/MeOH:
30% H20 2 10ml
MeOH 50ml
Store at 4°C
Deterqent Mix: (500ml) Final Cone’ Volume
NP-40 1% 5ml
20% SDS 1% 25ml
Deoxycholate (Na+salt) 0.5% 2.5g
1M Tris pH8 50mM 25ml
0.5M EDTA 1mM 1ml
5M NaCI 150mM 15ml
H20 429ml
80Hybridisation mix: 
Formamide 
20x SSC 
20% SDS
10% Boehringers blocking
reagent
tRNA
Heparin
Final Cone’ 
50%
5x
2%
2%
250pg/ml
100pg/ml
Volume
25ml
12.5ml
5ml
10ml
1.25ml
100|jl
Store at -20°C
Solution X: (50ml)  Final Cone’  Volume
Formamide  50%  25ml
20 x SSC  1%  2.5ml
H20  17.5ml
Store at 4°C
MAB: PH7.5
11.6g  Maleic acid  (100mM),  8.76g  NaCI  (150mM),  8g  NaOH  in  1 1  
H20. Autoclave.
MABT:
0.1% Tween-20 in MAB (1ml in 11).
8110% Boehrinqers Blocking Reagent:
100ml MAB, 10g BBR (powder at 4°C). Autoclave. 
Store at -20°C
NTMT: Final Cone’ Volume
5M NaCI 0.1M 2ml
1M Tris pH 9.5 0.1M 10ml
1M MgCI2 5mM 5ml
Tween-20 0.1% 100pl
Water to 100ml
82Chapter 3: Spatiotemporal development of neural crest cells, 
smooth muscle and interstitial cells of Cajal within the human
gastrointestinal tract.
833.1  Introduction
3.1.1  Overview
The  developmental  timings  and  patterns  of  migration  of  the  vagal  and 
sacral  neural  crest  populations  that  colonise  the  ENS  have  been  well 
documented  in  mouse  and  chick  models  (Burns  2005).  However,  there  is  a 
paucity of information  concerning  ENS development in  human  embryos.  Ethical 
considerations  and  the  difficulty  of  obtaining  human  embryonic  and  foetal 
material  have been the main barriers to progressing  in this area.  Utilising tissue 
obtained  from  the  Human  Developmental  Biology  Resource  (HDBR),  jointly 
funded  by the Medical  Research  Council and the Wellcome Trust,  and from the 
MRC  tissue  bank  at  Hammersmith  Hospital,  London,  we  aimed  to  use 
immunohistochemistry to address basic questions relating to the formation of the 
functional innervation in the human gastrointestinal tract.
Functional  gut  requires  the  interaction  of three  components  in  order  to 
generate  successful  motility;  these  are the  ENS  which  comprises  neurons  and 
glia,  the  smooth  muscle,  and  the  interstitial  cells  of Cajal.  The  ENS  generates 
signals,  mediated  by  the  ICCs,  which  control  the  activity  of  the  gut  smooth 
muscle.  By  using  antibodies  to  p75N TR   (the  low-affinity  neurotrophin  receptor 
expressed  by  neural  crest  cells),  a  smooth  muscle  actin  (SMA)  (a  structural 
protein  expressed  in  the  musculature  of the gut),  and  c-kit  (a  receptor tyrosine 
kinase expressed  by interstitial cells of Cajal) the appearance and development 
of these three cell types was documented.
843.1.2 The human enteric nervous system
As previously discussed in section  1.2, the ENS is derived from neural crest cells 
and their development is well understood in animal models. Prior to commencing 
this  study  the  precise  timings  of  ENS  colonisation  by  neural  crest  cells  was 
unknown  in  human  embryonic  development.  Several  ultrastructural  and 
immunohistochemical studies of embryonic gut have previously been carried out, 
though these dealt with later stage embryos than available here from gestational 
week  nine  or  ten  (Fekete,  Resch,  and  Benedeczky  1995;  Fekete  et  al.  1996; 
Benedeczky,  Fekete,  and  Resch  1993;  Vaos  1989;  Brandt,  Tam,  and  Gould 
1996).  By this time  neurons are  present throughout the  myenteric plexus along 
the entire length of the gastrointestinal tract.
To identify neural crest cells we chose to use the low-affinity neurotrophin 
receptor  p75NTR,  a  well  recognised  marker of  neural  crest  (Baetge,  Schneider, 
and  Gershon  1990).  In addition to labelling the  neural crest derived  ENS,  some 
crest derived  extrinsic  nerve fibres  associated  with  the  gut,  such  as  the  vagus 
nerve, are also labelled.
853.1.3 Enteric musculature
The smooth musculature of the gastrointestinal tract, which is derived from 
lateral plate splanchnic mesoderm  (Roberts 2000),  consists of two components, 
the muscularis mucosae and the muscularis propria. The former structure sends 
projections  into  the  mucosal  layer and  is  thought to  play  a  role  in  the  lumenal 
mixing and  absorbtion of gut contents. The latter comprises the longitudinal and 
circular muscle layers, and is involved in the motility of the gut.
The  sequence  in  which  these  muscle  layers  form  is  well  accepted.  The 
circular muscle  layer forms first,  followed  by  longitudinal  muscle  and  finally the 
muscularis mucosae. The precise developmental nature of the formation of these 
muscle layers is still  unclear.  Myoblasts can be induced  by intestinal epithelium; 
however,  studies  have  reported  radial  migrations  by  circular  muscle  into  the 
presumptive longitudinal muscle layer region prior to the appearance of that layer 
(Masumoto et al. 2000). The role of these projections is unknown.  It may be that 
they provide inductive factors to the mesenchymal cells in that region or they may 
simply incorporate themselves into that layer. Similar centripetal projections arise 
from the circular muscle layer towards the presumptive muscularis mucosae.
Adult  gut  smooth  muscle  is  comprised  mainly  of  a  and  y  isoforms  of 
smooth muscle actin (Fatigati and Murphy 1984). a-smooth muscle actin (a-SMA) 
appears earliest within myoblasts and was chosen to act as the marker of smooth 
muscle in this investigation.
863.1.4 Interstitial cells of Cajal
Interstitial  cells  of  Cajal  (ICCs)  were  first  described  in  1895  by  Cajal. 
These  cells,  which  were first  identified  in  the  myenteric  plexus  of rabbits,  were 
initially  named  interstitial  neurons.  Cajal  suggested  that due to their positioning 
between the muscle and  ENS they may have been  responsible for regulation of 
muscle activity.  Since then  ICCs  have  been found  in  several  other locations  of 
the  gastrointestinal  tract  (Hirst  and  Edwards  2004).  ICCs  vary  in  their  position 
relative  to  the  two  different  plexuses  and  muscle  layers  depending  upon  the 
region of gut studied.  The function of these cells is  now known to alter with this 
positional  change.  Indeed  six differing  types  of ICC  have  been  identified  using 
immunohistochemical staining (Burns et al. 1997).
ICCs can be identified by immunostaining for the transmembrane tyrosine 
kinase receptor c-kit (Wester et al.  1999; Ward et al.  1994;  Huizinga et al.  1995), 
including  within  the  human  gut  (Wester  et  al.  1999).  The  c-kit  receptor  is 
essential  for the  formation  of a  functional  network  of  ICCs  (Ward  et  al.  1995; 
Huizinga  et  al.  1995)  although  not  all  ICCs  express  c-kit  (Torihashi,  Horisawa, 
and  Watanabe  1999).  Three  roles  for  ICCs  have  been  suggested  by 
morphological  studies:  1)  pacemaker  cells  of  the  musculature  of  the 
gastrointestinal  tract;  2)  facilitators  of  electrical  activity  within  the  gut;  3) 
mediators of neurotransmission between the ENS and musculature.
The  precise  germ  layer  origin  of  ICCs  was  unclear  until  comparatively 
recently. Staining shared between neurons and ICC, such as methylene blue and
87silver  chromate,  convinced  Cajal  and  others  that  they  were  of  neural  origin. 
Analysis  of  the  cellular  structure  of  ICC  indicated  a  closer  resemblance  to 
fibroblasts  and  smooth  muscle.  This,  combined  with  the  close  association  of 
ICCs and enteric neurons, suggested a specialised support cell role (Thuneberg 
1982; Thuneberg, Rumessen, and Mikkelsen 1982).
Work in  both  mammals (Young et al.  1996)  and  avians (Lecoin,  Gabella, 
and  Le  Douarin  1996)  revealed  the  non-neural  crest  origin  of  ICCs.  Lecoin 
approached the problem with two sets of experiments. When vagal NC from quail 
embryos  was  grafted  into  chicks,  ICCs  in  the  gut  did  not  contain  the  quail 
nucleus,  and  therefore  were  of  chick  origin.  In  the  second  experiment,  organ 
culture  using  the  chorioallantoic  membrane  of  developing  chick  embryos  was 
used  to culture  isolated  E3.5  hindgut.  At this  stage  NCC  have  not  reached  the 
hindgut (Burns and Le Douarin 1998) and so ICC development in the absence of 
crest  cells  could  be  assayed.  In  the  cultured  gut,  c-kit  expressing  cells  were 
found  at the outer regions of the circular muscle layer.  This would  coincide with 
the  correct  location  of  ICC  in  association  with  myenteric  ganglia  in  a  normal 
hindgut.  The work by Young  et al  in the same year (Young  et al.  1996)  used  a 
similar approach to Lecoin by culturing E9.5-E14 mouse hindgut segments within 
the  kidney capsule.  Again  gut explants  of this  age  lack  neural  crest precursors 
and  results  from  these  experiments  concur  with  Lecoin’s  findings  that  ICCs 
neither arise from the neural crest nor require its presence to differentiate. These 
studies have shown conclusively that ICCs are of mesenchymal origin
883.1.5 Aims
The purpose of this  invesitgation  is to describe the spatiotemporal development 
of functional  human embryonic gut between weeks 4 and  14 of gestation.  Using 
antibodies to  previously described  markers of neural  crest cells,  enteric smooth 
musculature and  interstitial cells of Cajal the positions and origins of these three 
cell types will be catalogued and their relationship to each other compared.
Through the  HDBR  and  MRC tissue  bank multiple samples of each week were 
obtained  if  possible  though  in  some  instances  only  a  single  sample  was 
availbale.
Table 3.1: Number of embryos collected for each gestational age.
Gestational age in 
weeks
4 5 6 7 8 9 11 12 14
N= 3 2 2 3 5 4 3 4 1
893.2 Results
3.2.1 Neural crest cells:
At week 4,  the  earliest stage  examined,  neural  crest  cells  have  already 
delaminated from the neural tube and begun to migrate ventrally along previously 
described  pathways  lateral  to  the  dorsal  aorta  (Fig  3.1  a).  Crest  cells  migrate 
towards  the  midline  ventral  to  the  dorsal  aorta  and  have  reached  the  dorsal 
portion of the presumptive foregut (Fig 3.1  b). The degree of gut colonisation by 
these  NCC  is  sparse  and  at  this  stage  of  development  they  are  distributed 
throughout the  outer gut  mesenchyme.  More  caudal  in  the  presumptive  midgut 
NCCs have colonised the ventral portion of the gut mesenchyme as well as more 
dorsally and are present within the outer regions of the mesenchyme in a diffuse 
and  random  pattern  (Fig  3.1  c). At week 5 there  is  no dramatic  increase  in the 
distance neural crest cells have migrated along the gut.  In the foregut the dorsal 
half  of  the  gut  remains  the  only  region  colonised  by  NCC  (Fig  3.1  d)  and 
throughout  the  midgut  NCC  have  colonised  more  ventral  portions  of  the 
mesenchyme (Fig 3.1 e,f). In the foregut, however, NCC have begun to coalesce 
into small interconnected groups thus beginning to form primitive ganglia (Fig 3.1 
d). The gut tube has increased in length by this time and the proximal and distal 
midgut regions do  not differ significantly in their NCC  colonisation  patterns  (Fig
3.1  e,f). Like the NCC of the foregut, those in the midgut have begun to coalesce 
into tighter groups.
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Figure 3.1.  Development of p75NTR-immunopositive neural  crest cells.
(a) At week 4,  p75NTR-labelled  cells  (brown)  migrated  away from the  neural tube 
(NT),  as  streams  of  cells  (arrows)  lateral  to  the  dorsal  aorta  (DA),  (b)  NCC 
(arrows)  were  scattered  in  the  dorsal  aspect  of the  foregut  mesenchyme,  (c)  In 
the  proximal  midgut,  adjacent  to  the  liver  (L),  NCC  (arrows)  were  scattered 
across  the  width  of the  undifferentiated  mesenchyme,  (d)  At week  5,  NCC  were 
present  in  the  dorsal  foregut,  where  they  had  accumulated  into  small  groups  of 
cells  (arrows),  (e)  In  the  proximal  midgut,  adjacent to  the  liver  (L),  NCC  (arrows) 
were  present  throughout  the  majority  of  the  mesenchyme,  although  the  ventral 
aspect  of the  developing  gut was  sparsely  colonised  (asterisk),  (f)  In  the  midgut, 
small  groups of NCC  encircled  the gut,  with the  majority of cells  distributed  in the 
dorsal gut wall  (arrows).  Scale bar = 200pm  (a);  100pm  (b-f).
-Dr.Alan  Burns assisted  in the production and  presentation  of this figure.
91At week 6 the gut can be divided into foregut, midgut and hindgut, with the 
stomach present as a discernable structure. Encircling the lumen of the stomach, 
small aggregates of NCC are present in the outer mesenchyme approximating to 
the position of the future myenteric plexus (Fig 3.2 a). Also present are extrinsic 
fibres protruding into the outer mesenchyme.  In the midgut NCC have coalesced 
into small clusters of cells joined  by p75N TR  positive projections (Fig 3.2 b,c).  In 
more caudal midgut NCC have also coalesced, but here the clusters are less well 
defined  and  lack  the  distinct  fibres  linking  them  (Fig  3.2  d).  At  higher 
magnification these clusters can be clearly seen to contain  upwards of 3-4 cells 
(Fig  3.2  e).  Neural  crest  cells  located  more  caudal  in  the  midgut  have  not yet 
begun  to  form  clusters  and  are  restricted  to  a  tight  band  in  the  outer 
mesenchyme (Fig  3.2 f). The  hindgut is  not yet colonised  by NCC  at this stage 
(Fig 3.2 f)
Distinct  ganglia  of  the  forming  myenteric  plexus  are  present  in  the 
eosophagus  and  stomach  of week  7  embryos  (Fig  3.3  a,b).  In  the  duodenum 
these  distinct  ganglia  are  not  yet  present.  Instead  NCC  are  arrayed  as  a 
condensed  web  of  small  clusters  of  cells  in  the  region  of  mesenchyme 
approximating to the future myenteric plexus (Fig 3.3 c). The same is true of the 
proximal and  distal  intestine although  progressively more caudal regions appear 
less well developed, exhibiting few instances of coalescence at this time (Fig 3.3 
d,e). At week 7 the hindgut is colonised  by NCC (Fig 3.3 f),  and these cells are 
arranged as a loose web of cells dispersed widely throughout the mesenchyme.
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Figure  3.2.  Development of p75NTR-immunopositive neural crest cells.
(a)  At  week  6,  NCC  (brown)  were  distributed  within  the  wall  of  the  stomach 
(arrows).  p75NTR-immunostaining,  corresponding  to  the  vagal  nerve  and  its 
branches,  was  also  present  adjacent  to  the  stomach  (arrowheads),  (b-e)  In  the 
midgut,  NCC  (arrows)  were  present  in  the  outer  layers  of  the  developing  gut. 
Groups of cells  (c,  arrows),  were  interconnected  by fine  immunopositive fibres  (c, 
arrowheads).  Individual  cell  bodies  could  be  identified  within  the  small  cell 
clusters  (e,  arrowheads).  Although  the  midgut  contained  many  NCC,  the  hindgut 
was free from  crest cells (f).  L,  liver;  mg,  midgut;  hg,  hindgut.
Scale  bar =  200pm  (a,  b);  100pm  (c,  d,  f,).
-Dr.Alan  Burns assisted  in the production and  presentation of this figure.
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Figure 3.3.  Development of p75NTR-immunopositive neural crest cells.
(a) At week 7,  p75NTR-immunostaining  (brown) was observed  in  the esophagus, 
in  cells  located  external  to the  circular muscle  layer  (arrows),  (b)  In  the  stomach, 
labelling  was  apparent  in  groups  of  cells  (arrows)  within  the  muscle  layers, 
corresponding  to  primitive ganglia,  (c,  d)  In  the  duodenum  and  proximal  intestine 
respectively,  immunostaining  (arrows)  encircled  the  gut  in  a  ring  external  to  the 
circular  muscle  layers,  (e)  In  the  distal  intestine,  p75NTR-positive  cells  (arrows) 
were  distributed  within  the  developing  muscle  layers,  (f)  In  the  colon, 
immunopositive  cells  (arrows)  were  scattered  throughout the  undifferentiated  gut 
mesenchyme.  Scale bars =  100pm  (a,  c,  d, f);  50pm  (b,  e).
94In the eosophagus of week 8 embryos discrete groups of cells are present 
within the myenteric ganglia (Fig 3.4 a). Also present at this stage are protrusions 
into the  submucosal  plexus from  the  myenteric  plexus  in  the  oesophagus.  The 
myenteric  plexus  of  the  stomach  contains  distinct  ganglia  and  possesses  an 
organised appearance (Fig 3.4 b). From the duodenum to the distal colon a clear 
gradient of development is apparent (Fig 3.4 c-f).  In the duodenum, ganglia are 
well  defined  and  tightly  restricted  to the  myenteric  plexus  region,  although  they 
do not appear organised as yet (Fig 3.4 c).  In the proximal intestine neural crest 
cells are restricted to the outer mesenchyme (Fig 3.4 d). The ganglia appear less 
well  formed  than  those  in  the  duodenum,  being  more  bulbous  and  rounded  in 
appearance.  In the distal  intestine,  NCCs are arranged  as  interlinked  clusters of 
cells rather than ganglia, and these are present in a wide band encircling the gut 
(Fig 3.4 e).  The  hindgut contains  NCCs organised  as small  interlinked  clusters, 
dispersed throughout much of the mesenchyme (Fig 3.4 f).
By  week  11  the  first  migrations  from  the  myenteric  plexus  to  the  sub­
mucosal  plexus occur in the midgut (Fig  3.5 b,c).  In the  most rostral  regions of 
midgut primitive  submucosal ganglia  are present (Fig  3.5 c).  More caudally the 
colonising streams of cells migrate through the circular muscle layer (Fig 3.5 b).
95WEEK 8
a   v   d
4
/   ’  V 
I   ^
W i  •
*  f  '.4  «c ‘i
<  ;  '  ;  '  <
rox  intst
v  >
<» i  •
stom  6   *  '  a  v  dist  intst
% * £ K
ii.r
-  y * -  - fTf * - - *   *  *\
"  t  t  f
*  A »  *4
T
\
V®   >
% A
Si-.
•   ft
tv>  ^   4*S
%   * . 2 *"  '2**
/
t  ♦  ~   i  • /
/   -  i   6, 4 ^
duod dist colon
.  j*
V v   »   »  -  t  I >
S *   V  V
^   *% -  .
Figure 3.4. Development of p75NTR-immunopositive neural crest cells.
(a) At week 8, p75NTR-immunostaining (brown) was observed in the esophagus, 
in cells located external to the circular muscle layer (arrows) and as projections to 
the  submucosa  (arrowheads),  (b)  In  the  stomach,  labelling  was  apparent  in 
groups  of  cells  (arrows)  within  the  muscle  layers,  corresponding  to  primitive 
ganglia,  (c,  d)  In  the  duodenum  and  proximal  intestine  respectively, 
immunostaining (arrows) encircled the gut in a ring external to the circular muscle 
layers,  (e)  In the distal  intestine,  p75NTR-positive cells (arrows) were distributed 
within  the  developing  muscle  layers,  (f)  In  the  colon,  immunopositive  cells 
(arrows) were scattered throughout the undifferentiated gut mesenchyme.
Scale bars = 100pm (a, c, d, f); 50pm (b, e).
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Figure 3.5.  Development of p75NTR-immunopositive neural crest cells.
(a)  At  week  11,  in  the  intestine,  individual  NCC-containing  ganglia  (asterisks) 
were  apparent within the  myenteric  plexus  region  (myp)  of the small  intestine,  (b, 
c)  Projections  (arrow)  from  the  myenteric  plexus  cells,  traversed  the  circular 
muscle  layer  (cm)  and  interconnected  with  areas  of  immunostaining  in  the 
presumptive submucosal  plexus (smp)  region.  Scale bar =  50pm  (a-c).
973.2.2 Smooth muscle development:
W eak  aSM A   staining  is  observed  at  week  7  in  the  foregut  and  midgut 
although  this  is  barely  observable  (data  not  shown).  A  clear  positive  aSM A 
immunohistochemical  signal  appears  along  the  length  of  the  gut  at  week  8  of 
gestation  (Fig  3.6).  The  first  muscle  layer  to  appear  positively  stained  is  the 
circular  muscle  layer  located  internal  to the forming  myenteric  plexus.  This  layer 
appears  thickest  in  the  eosophagus  (Fig  3.6  a),  and  is  also  the  most  well 
developed.  In  contrast to  the  developing  circular  muscle  of the  eosophagus  the 
muscle  in  the  colon  appears  as  a  thinner,  more  diffuse  band  of  aSM A 
immunoreactivity,  indicating a  less well developed  population of cells (Fig 3.6 e).
By  week  11  the  full  length  of  the  gut  possesses  two  distinct  layers  of 
strong  SMA  immunoreactivity  corresponding  to  the  circular  and  longitudinal 
layers,  and  also a weaker region which will  develop  into the  muscularis  mucosae 
(Fig 3.7 a).  Enteric ganglia,  stained  for p75NTR,  can  be  seen  positioned  between 
the  circular  and  longitudinal  muscle  layers  with  occasional  fibres  protruding 
through the circular layer to the future submucosal  plexus  region. At week  12 the 
different  layers  appear  more  condensed  and  the  difference  in  thickness  can  be 
seen,  with  the  circular  layer  being  noticeably  thicker  than  the  longitudinal  layer 
(Fig  3.7  b).  At  week  14  the  musculature  of the  gut  appears  organised  with  the 
circular  and  longitudinal  layers  clearly  defined  by  strong  SM A  immunostaining. 
These  layers  surround  the  p75NTR-labelled  enteric  ganglia  of  the  myenteric 
plexus,  from which fibres protrude  into the submucosal  and  muscularis  mucosae. 
The muscularis mucosae is strongly stained for SM A immunoreactivity .
98WEEK 8
Figure 3.6.  Development of SMA-immunopositive smooth  muscle layers.
(a)  At  week  8,  in  the  esophagus,  the  circular  muscle  layer  (cm)  was  well 
developed  and  a  dense  band  of  cells  was  strongly  immunopositive  for  SMA 
(green).  p75NTR-positive  cells  (red)  were  grouped  into  presumptive  ganglia 
(arrows),  external  to  the  circular  muscle,  (b)  In  the  stomach,  SMA  labelling  was 
apparent  in  the  developing  muscle  layers  (cm).  p75NTR-labelled  cells  (arrows) 
were  scattered  throughout  the  smooth  muscle,  (c)  In  the  proximal  intestine,  the 
circular muscle  comprised  a  narrow band  of SMA stained  cells  (cm,  arrowhead). 
p75NTR-positive  NCC  were  arranged  external  to  the  circular  muscle,  and  had 
coalesced  to  form  the  presumptive  myenteric  plexus  (arrows),  (d)  In  the  distal 
intestine,  the  circular  muscle  (cm,  arrowhead)  was  less  dense  than  in  the 
proximal  intestine.  Some  p75NTR-positive  cells  were  grouped  together  as 
primitive  ganglia  (arrows),  but  the  majority  of  labelled  cells  were  scattered 
throughout  the  gut  mesenchyme,  external  to  the  developing  circular  muscle 
layers,  (e)  In  the  colon,  SMA-labelling  was  sparse  and  the  circular  muscle  layer 
(cm) was  at an  early  stage  of development.  p75NTR-positive  cells  (arrows)  were 
scattered  throughout the  gut  mesenchyme.  Scale  bars  =  100pm  (b,  c,  d);  50pm 
(a,  e).
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Figure  3.7.  Development  of  SMA-immunopositive  smooth  muscle  layers  in 
hindgut.
(a)  At  week  11,  SMA-staining  (green)  was  apparent  in  the  circular  (cm)  and 
longitudinal  (Lm)  muscle  layers,  located  on  either  side  of  the  p75NTR-positive 
(red)  cells  (arrows)  of  the  presumptive  myenteric  plexus.  Occasional  areas  of 
p75NTR  immunoreactivity were also apparent in the  region  internal to the circular 
muscle  layer,  corresponding  to  the  presumptive  submucosal  plexus  (double 
arrowheads),  (b)  At  week  12,  the  circular  (cm)  and  longitudinal  (Lm)  muscle 
layers  were  strongly  immunopositive  for  SMA.  Between  the  muscle  layers, 
p75NTR  labelling  was  apparent  in  groups  of  cells  comprising  myenteric  ganglia 
(arrows),  (c)  At  week  14,  SMA  labelling  was  strong  in  the  circular  (cm)  and 
longitudinal (arrowhead,  Lm)  muscle  layers,  and weak in the muscularis mucosae 
(mm),  adjacent  to  the  villi  (v).  The  walls  of  blood  vessel  within  the  submucosa 
were  also  immunopositive  for  SMA  (asterisks).  p75NTR  staining  was  present 
within  ganglia  of  the  myenteric  plexus  (arrows)  and  in  nerve  fibres  within  the 
submucosa  (double arrowheads).  Scale bars =  50pm  (a,  b);  100pm  (c).
100(Fig  3.7  c).  Also  stained  are  the  walls  of  blood  vessels  running  through  the 
submucosa.
3.2.3 Development of the Interstitial cells of Cajal:
Immunoreactivity for c-kit, the marker for Interstitial cells of Cajal,  begins to 
appear at week  9.  Diffuse  staining,  in  the future  position  of ICCs  associated  with 
the  myenteric  plexus,  is  present  in  the  mid  and  hindgut  (Fig  3.8 A,B)  Already 
these  c-kit  positive  cells  are  found  in  close  association  with  the  developing 
enteric ganglia (Fig 3.8 B).  ICCs  become organised  the  most rapidly of the three 
tissues  investigated  here,  and  as  a  result  identifying  any  rostrocaudal  wave  of 
development  is  difficult  with  the  samples  available.  At  week  11  the  positive 
immunostaining  for c-kit  has  narrowed  to  only those  regions  in  close  association 
with  the  forming  myenteric  ganglia  (Fig 3.8 C,D).  By  week  12  ICCs  appear well 
organised,  being  closely  and  exclusively  associated  with  the  myenteric  ganglia 
and  bipolar  in  appearance  (Fig  3.8  E,F).  ICCs  at  week  14  (Fig  3.8  G)  appear 
closely associated with enteric ganglia of the myenteric plexus.
101MIDGUT HINDGUT
102Figure 3.8. Development of Kit-immunopositive interstitial cells of Cajal (ICC).
(A) At week 9,  Kit immunostaining (red) was present at low levels (arrows) within 
the  developing  circular  muscle  (cm)  of  the  midgut.  (B)  In  the  hindgut, 
immunolabelling (arrows) was apparent within the developing muscle.  Unlabelled 
areas,  corresponding  to  presumptive  myenteric  ganglia  (asterisks)  were 
apparent.  (C) At week  11,  in the midgut,  Kit-positive  ICC  (arrows) were  located 
on  either side  of the  presumptive  myenteric  plexus  cells  (asterisks).  (D)  In  the 
hindgut, Kit staining was widespread within the developing smooth muscle layers, 
particularly  surrounding  (arrows)  the  presumptive  myenteric ganglia  (asterisks).
(E)  In  the  midgut  at week  12,  Kit-positive  cells  (arrows)  were  restricted  to  the 
areas surrounding ganglia (asterisks),  a pattern similar to that within the hindgut
(F).  (G)  At  week  14,  in  the  hindgut,  Kit-positive  ICC  (arrows)  surrounded 
myenteric  ganglia  (asterisks).  Kit  staining  was  not  observed  within  the 
submucosa (sm).
Scale bars = 100pm (A, C-F); (B, G).
1033.3 Discussion
In this study the spatiotemporal colonisation of the human gastrointestinal 
tract by three  cell  types  essential for the formation  of a fully functional  and  co­
ordinated neuromuscular apparatus in the gastrointestinal tract was documented: 
1) The neural crest-derived enteric precursors, which contribute the neurons and 
glia  of the  ENS;  2)  The  enteric smooth  muscle,  which  derives from  splanchnic 
mesenchyme,  and  forms  the  contractile  tissue  of the  longitudinal  and  circular 
muscle  layers;  3) The  interstitial  cells  of Cajal,  also derived  from  mesenchyme, 
which  mediate neuromuscular signalling and  underlie the generation of the slow 
wave electrical activity of the smooth muscle.  Immunohistochemistry using three 
well  established  markers  for  these  cell  types  was  employed  to  visualise  their 
spatiotemporal development at known stages.
The low affinity neurotrophin receptor p75N TR  has been extensively used to 
label  NCC  in species including Xenopus laevis (Sundqvist and Holmgren 2004), 
mouse (Chalazonitis et al.  1998b; Young et al.  1998; Young et al.  1999; Young, 
Bergner, and Muller 2003), human (Fu et al. 2003), and other mammals including 
sheep,  horse,  cow,  pig,  rabbit and  rat (Esteban  et al.  1998).  In  agreement with 
the recent findings of Fu et al (Fu et al.  2003),  p75N TR -positive NCC were found 
to colonise the human gut in a rostro-caudal direction between weeks 4 and 7 of 
embryonic  development  (Wallace  and  Burns  2005).  At week 4,  p75N TR -positive 
NCCs from the vagal region were found in the dorsal aspect of the foregut having 
migrated  via  a  dorso-lateral  route from  the vagal  region  of the  neural  tube.  As 
colonisation  progresses  these  cells  migrate  in  a  rostrocaudal  direction  through
104the gut mesenchyme,  encircling the gut,  proliferating and forming, first chains of 
cells  and  then  primitive  ganglia.  This  rostrocaudal  pattern  of  migration  is  the 
same as that  reported  in  other organisms  such  as fish  (Shepherd  et al.  2004), 
avians  (Burns  and  Le  Douarin  2001),  mouse  (Young  et  al.  1998),  and  most 
recently  humans  (Fu  et  al.  2003;  Fu  et  al.  2004;  Wallace  and  Burns  2003). 
Considering these comparable studies of NCC  migration  in  conjunction with the 
rostrocaudal  migration  seen  here,  it  can  be  surmised  that  vagal  neural  crest- 
derived enteric precursors colonise the entire length of the gut and contribute to 
at  least the  majority  of neurons  and  glia  along  that  length.  This  idea  is further 
supported by work investigating the expression of RET in the developing human 
gastrointestinal tract, which showed that expression was confined to neural crest 
cell-derived  populations  (Attie-Bitach  et  al.  1998).  At the  time  of this  study  no 
markers  capable  of  segregating  between  vagal  and  sacral  derived  NCCs  are 
available.  Therefore  it  is  impossible  to  state  whether  there  is  any  sacral 
contribution to the ENS  in  humans, the timings thereof should this occur,  or the 
extent to which  they  contribute.  No  p75N TR   positive  cells  were  observed  in  the 
hindguts of embryos prior to the arrival of the migration front of the vagal derived 
cells  indicating  that  any sacral  contribution  arrives  after the  colonisation  of the 
hindgut  by  the  vagal  derived  NCCs,  findings  consistent  with  those  in  animal 
models (Burns and Douarin 1998).
In  addition  to  the  rostrocaudal  migration  of  NCC  along  the  gut  between 
weeks  4  and  7,  this  study  reveals  a  considerable  amount  of  variation  in  the 
distribution of crest cells between differing gut regions at a single time point.  For 
example,  at week 7 although the entire length of the gut has been colonised  by
105NCC,  their appearance differs greatly between  the foregut,  in  which  NCC  have 
coalesced  to  form  primitive  ganglia,  the  midgut,  in  which  NCC  are  loosely 
arranged in the outer mesenchyme, and the hindgut, in which NCC are scattered 
throughout the  mesenchyme.  Therefore the  maturation  of the  ENS  also  occurs 
along  a  rostrocaudal  gradient  with  the  myenteric  plexus  forming  in  the 
oesophagus some three weeks prior to the hindgut.
After initially being  scattered  throughout the mesenchyme of the gut,  the 
NCCs are restricted to the outer mesenchyme, thus forming a primitive myenteric 
plexus,  consistent with  the  pattern  seen  in  model  organisms  (Kapur,  Yost,  and 
Palmiter 1992; Gershon, Chalazonitis, and Rothman 1993; McKeown, Chow, and 
Young  2001;  Burns  and  Douarin  1998).  In  these  models  the  formation  of the 
submucosal plexus occurs as a second centripetal colonisation event originating 
from the myenteric plexus with cells migrating through the circular muscle layer. 
Here centripetal migration by NCC from the myenteric to the submucosal plexus 
is observed in the oesophagus at week 8 and in the midgut at week 11.
The environmental cues which guide and trigger this secondary migration 
event  remain  to  be fully  determined.  Ligands  such  as  GDNF  and  ET-3,  of the 
RET  and  EDNRB  signalling  pathways  respectively,  are  expressed  in  the  gut 
mesenchyme at these times (Suvanto et al.  1996;  Natarajan et al. 2002;  Leibl et 
al.  1999),  although  not  in  a  pattern  which  coincides  with  the  NCC  migration 
through the circular muscle layer. Another prospective pathway determining this 
event is signalling through the receptor Deleted  in Colorectal Cancer (DCC) and
its  ligand  netrinl.  DCC-expressing  NCCs  show  an  affinity  for  regions  of  high
106netrin expression, which in the gut mesenchyme is the submucosal region (Jiang, 
Liu,  and  Gershon  2003).  Therefore  NCCs  may  possess  the  ability to  enter the 
submucosal region from the very start of their migration, but as yet undetermined 
negative  chemotactic  signals  restrict  the  initial  domain  available  to  that  of the 
future  myenteric  plexus.  Later  this  signal  is  removed  and  the  chemoattractive 
properties  of  DCC  and  netrinl  act  on  a  subset  of  ENS  precursors  to  initiate 
centripetal  migration  and  formation  of the  submucosal  plexus.  Such  a  system 
occurs  in  the  chick where  collapsin-1  initially  inhibits  neuronal  projections from 
the nerve of Remak from penetrating the gut wall (Shepherd and Raper 1999).
Using  antibodies  against a  smooth  muscle  actin  (aSMA),  a  rostrocaudal 
maturation  of  enteric  smooth  muscle  was  observed  beginning  after  NCC 
colonisation of the gut. A broad band of aSMA staining was evident at week 8 in 
the oesophagus, and week 11  in the hindgut, corresponding to the position of the 
future circular muscle  layer.  Other work  has  reported  such  gradients  in  smooth 
muscle  maturation  (Fu  et  al.  2004)  but the  link  between  immunohistochemical 
and structural development is poorly understood.  Ultrastructural investigations of 
muscle  development  in  the  gut  have  not  revealed  such  a  gradient  (Gabella 
2002).
It was suggested recently by Fu et al (Fu et al. 2004), that the circular and 
longitudinal  muscle  layers  appear at the  same  time  during  development of the 
gut  in  humans,  and  that  they  differentiate  in  a  rostrocaudal  manner  between 
weeks  7  and  9.  As  stated  above  the  accepted  pattern  of  development  in  lab 
animals  involves  the  formation  of  the  circular  muscle  prior  to  the  longitudinal
107muscle. This investigation provides no evidence of any aSMA positive staining in 
the  longitudinal  muscle  layer of the midgut and  hindgut at week 8 whereas the 
circular  muscle  layer  in  these  locations  is  aSMA  positive  at  this  stage.  These 
findings  suggest that the  longitudinal  muscle  matures  after the circular muscle. 
This is in agreement with reports of delayed longitudinal muscle maturation in the 
gut  of  the  chick  embryo  using  the  smooth  muscle  marker  13F4  (Burns  and 
Douarin 1998). The timings of muscularis mucosae formation observed here also 
co-incide with established patterns (Roberts 2000).
The transmembrane tyrosine kinase receptor c-kit and its ligand Stem Cell 
Factor (SCF) are essential for development of a normal ICC network (Ward et al. 
1994; Ward et al.  1995), although a subpopulation of ICC do not express the c-kit 
receptor (Torihashi,  Horisawa, and Watanabe 1999).  Studies in avians show that 
during development the c-kit receptor is expressed  at the outer boundary of the 
circular muscle  and  SCF  is  expressed  within  the  circular muscle  layer  (Lecoin, 
Gabella,  and  Le  Douarin  1996).  A second  source of SCF from  enteric  neurons 
has also been  reported  (Torihashi et al.  1996). This  raises the issue of whether 
ICCs  can  form  a  complete  and/or functional  network  in  the  absence  of enteric 
neurons,  as would  be the case in  HSCR.  Evidence from aganglionic gut models 
in mice and chick suggest that the removal of enteric neuron sourced SCF does 
not  inhibit  the  formation  of  functional  networks  of  ICC  (Wu,  Rothman,  and 
Gershon  2000);  (Lecoin,  Gabella,  and  Le  Douarin  1996).  However,  the 
relationship  between  enteric  neurons  and  ICCs  in  humans  is  still  unclear with 
conflicting  reports  recently  described  (Huizinga  et  al.  2001;  Rolle  et  al.  2002; 
Newman et al. 2003).
108Using  antibodies  against  c-kit  ICCs  were  identified  from  week  9  in  the 
intestine,  after  the  colonisation  by  NCCs  and  differentiation  of  the  smooth 
muscle. ICCs do not appear to mature in a rostrocaudal pattern like the other cell 
types  reported  here.  ICC  maturation  is  rapid;  by  week  11  they  have  become 
restricted to the area  immediately adjacent to the developing  myenteric ganglia. 
This pattern of association  between the two cell types appears better defined  in 
the midgut than  hindgut at this time.  Other reports of this association have been 
made  recently  from  human  foetal  bowel  (Kenny  et  al.  1999).  This  association 
suggests that in the absence of enteric neurons, such as in  HSCR, the structure 
of any ICC network forming would be greatly disrupted,  although not necessarily 
dysfunctional  in  all  its  activities.  In  contradiction  to the timings  observed  in  this 
study,  Fu et al (Fu et al. 2004) describe the presence of c-kit positive cells within 
the myenteric plexus from week 12, with these cells migrating to the periphery of 
those ganglia at week 14. No c-kit positive cells were observed within the ganglia 
of the myenteric plexus in this study, although double labelling between c-kit and 
p75 was not carried out. The positioning of the staining found  here indicates that 
the ICC are located at the periphery of the myenteric ganglia by as early as week 
9 and  certainly  by week  11.  The formation  of the  ICCs  appears to  occur some 
time after the formation of the ENS and smooth muscle, as has been reported in 
the mouse embryo (Wu, Rothman, and Gershon 2000).
109Chapter 4: Investigating the role of RET in enteric nervous
system development
1104.1  Introduction
4.1.1 Ret, a dependence receptor candidate:
The role of the tyrosine kinase receptor RET has already been discussed 
in  section  1.4.1,  but this  dealt with  the  classical  neurotrophic  properties  of the 
RET  protein.  In  addition  to  the  established  signalling  roles  there  is  mounting 
evidence  to  suggest  that  RET  also  functions  as  a  dependence  receptor 
(Bordeaux  et  al.  2000).  The  term  dependence  receptor  describes  a  protein 
whose  expression  results  in  cellular  dependency  for  its  target  ligand(s) 
(Bredesen,  Mehlen,  and  Rabizadeh  2005).  Thus  in  addition  to  any  positive 
signalling  roles  which  result  in  processes  such  as  proliferation,  survival  , 
migration,  or  differentiation,  so-called  dependence  receptors  may  tranduce 
negative signals inducing programmed cell death.
Candidate proteins displaying dependence receptor characteristics include 
those  involved  in  nervous  system  development  and  tumour  formation  (Fang, 
Jass, and Wang  1998; Krygier and Djakiew 2001).  Ret is no exception, playing a 
key role in ENS development and also being associated with the cancer, multiple 
endocrine neoplasia type 2 (Borrello et al. 1995).
To date, ten dependence receptors have been described: p75N TR  (the low- 
affinity  neurotrophin  receptor),  DCC  (deleted  in  colon  carcinomas),  UNC5H1, 
UNC5H2,  UNC5H3,  AR  (androgen  receptor),  RET,  Integrin  av(33,  integrin  a5pi 
and  Ptc  (patched  -   the  sonic  hedgehog  receptor)  (for  review  see  (Bredesen,
i l lMehlen, and Rabizadeh 2005)). Of these, the majority are type 1  transmembrane 
receptors,  whereas  only  Ptc and  AR are  not.  RET  is the  only  receptor tyrosine 
kinase identified as a dependence receptor thus far.
4.1.2  Cell death:
Cells  inevitably  die  in  multicellular  organisms,  although  the  manner  in 
which they do so varies. Cell death can be a deliberate means to an end,  a tool 
for sculpting developing tissues into their required shape. To simplify greatly, cell 
death  can  be  thought  of as  organised  or  chaotic  (Fig  4.1).  Chaotic  cell  death 
arises through necrosis, the lysing of a cell as a result of trauma, most commonly 
damage to the  cell’s  plasma  membrane.  Organised,  or  physiological  cell  death 
takes the form of either autophagy or apoptosis, also known as programmed cell 
death (for review see Lockshin and Zakeri (2004)).
In  necrosis,  death  can  be  caused  through  physical  injury to  the  cell,  by 
infection,  infarcation,  or  inflammation.  The  uncontrolled  manner  of  death  may 
result  in  further  injury  or death  to  surrounding  tissues  as  the  cell  lyses  and  its 
contents  are  released  into  the  immediate  area.  In  such  cases  toxins  and 
infectious agents can then attack secondary targets.
Autophagic cell death is an extension of the day-to-day cellular process of 
autophagy,  in which  organelles are turned  over as  part of a  normal  metabolism 
and housekeeping process. Autophagic cell death is not apoptotic,  but may take 
place as part of preparations for apoptosis in some cells.
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Figure 4.1:
Modified from Lockshin and Zakeri, 2004
4.1.3  Apoptosis:
Specific  patterns  of  ultrastructural  change  are  observed  when  a  cell 
undergoes apoptosis. These events are part of the process which fragments the 
cell in such  a way that the cell  is destroyed without releasing  its contents.  Such 
apoptotic  fragments  are  subsequently  consumed  by  macrophages,  limiting
113damage to neighbouring cells.  In addition to these ultraskeletal changes nuclear 
compaction is undergone and the cell’s DNA is cleaved into small fragments.
Apoptosis  can  be  either  caspase  dependent  or  caspase  independent. 
Casapse  dependent  apoptosis  can  be  due  to  endoplasmic  reticulum  stress, 
death  receptor  linked  (via  caspase-8)  or  mitochondria-metabolism  linked  (via 
caspase-9),  also  known  as  the  intrinsic  pathway.  A  Bcl-2  dependent  non- 
mitochondrial/cytochrome-c  linked  system  also  presents  a  possible  method  of 
caspase  activation  (Marsden  et  al.  2002),  although  its  precise  pathway  is 
unknown.  It may not classify as a true third  pathway but instead  be a subset of 
caspase-8 related receptor linked apoptosis.
4.1.4  Caspases:
Caspases (cysteinyl aspartate-specific proteases) were first discovered  in 
the  nematode  worm,  Caenorhabditis  elegans,  and  were  recognised  as  being 
resposible  for  the  programmed  cell  death  essential  for  development  of  that 
organism  (Ellis  and  Horvitz  1986).  The  c.elegans  capase,  CED-3,  possessed 
close homology with the then human interlukin-ip-converting enzyme (ICE), now 
refered to  as  caspase-1  (Yuan  et al.  1993).  Caspase-1  has  not  been  shown  to 
regulate apoptosis itself but other members of the family do act as regulators of 
programmed cell death.
114Caspases  are  produced  as  inactive  zymogens  which  undergo  internal 
cleavage to produce the final active state.  Not all caspases are associated with 
apoptosis,  but those that are  can  be divided  into two  groups  based  upon  their 
actions,  initiators  and  effectors  (for  review  see  Wang,  Liu,  and  Cui  (2005)). 
Initiatiors  act  to  trigger  effector  capase  activity  by  cleaving  a  procaspase 
zymogen  into  its  active  caspase  form.  These  initiator  caspases  are  not  the 
exclusive machinery by which this can occur.  Other non-caspase proteases can 
also  induce  effector  caspase  activity.  Active  effector  caspases  cleave  target 
proteins  releasing  proapoptotic  fragments.  The  functions  of  capases  are  1)  to 
arrest  the  cell  cycle  and  inhibit  DNA  repair  mechanisms;  2)  inactivate  the 
inihibitor of caspases machinery (XIAP); 3) dismantle the cellular cytoskeleton in 
an organised fashion for removal by phagocytes.
4.1.5  Caspase-9 and the Apaf-1 apoptosome:
Caspase-9  is  amongst the  most  intensively  studied  caspases  due  to  its 
essential  role  in  the  “intrinsic”   pathway  of apoptosis.  It  is  encoded  by a  -35Kb 
region  and  comprises 9 exons located  at position  1p36.3-1p36.1  (Hadano et al.
1999).  A  wide  variety  of  foetal  and  adult  human  tissues  display  caspase-9 
expression.  Expression is seen as early as E7 in the mouse embryo (Kuida et al. 
1998) and is subsequently down-regulated at E15. Knockouts of caspase-9 result 
in  apoptosis-deficient  defects  of  the  nervous  system  including  enlarged  and 
malformed  cerebellum  (Kuida  et al.  1998).  Analysis  of caspase-3 expression  in 
such mutants reveals caspase-9 to be a key regulator of the apoptotic cascade.
115The  intrinsic  pathway  refers  to  the  activation  pathway  responsible  for 
caspase-9  related  apoptosis.  Caspase-9  is  activated  primarily  as  a  result  of 
signals arising from mitochondrial damage, for example due to  UV, toxins,  Nitric 
Oxide,  or  in  response  to  endoplasmic  reticulum  stress  signals  via  caspase-12. 
Key to the mitochondrial activation of caspase-9 is Apaf-1.
Apaf-1  (apoptotic  grotease-activating  factor-1)  is  activated  through  the 
release of cytochrome-c from mitochondria in  response to apoptotic signals.  It is 
the mammalian homologue of CED-4 found in  C.elegans which has been shown 
to  be  an  essential  part  of the  highly  organised  apoptotic  programming  in  that 
animal.  Apaf-1  alone  is  a  large  protein  of  130  kD  which  after  activation  by 
cytochrome-c  oligomerises to  form  a  700-1400  kD  caspase  activating  complex 
referred  to  as  the  Apaf-1  apoptosome.  Multiple  copies  of  caspase-9  are  then 
recruited  to the  complex through  caspase  recruitment domain  (CARD)  binding, 
and this in turn recruits the procaspase-3 zymogen. The act of oligomerisation of 
caspase-9 when recruited to the Apaf-1  apoptosome likely induces self-activation 
of caspase-9, in turn leading to procaspase-3 activation.
The  activation  of  initiator  caspases  is  unusual  in  that  like  their  effector 
relatives  they  undergo  autocatalytic  cleavage  to  acquire  their  active  form. 
However, the activity of caspase-9 depends more on  its incorporation to a larger 
complex than on its cleavage.  Incorporation of cleaved caspase-9 into the Apaf-1 
holoenzyme  complex  increases  activity  by  3  orders  of magnitude  compared  to 
unbound procasapse-9 zymogen (Stennicke et al.  1999). Mutated caspase-9 with
two mutations preventing cleavage of the zymogen to the recognised active form
116is still  incorporated  and  retains 40%  of wildtype activity  levels.  It is  unlikely that 
the  marginal  activity  of  caspase-9  when  not  part  of the  apoptosome  is  alone 
sufficient  to  activate  caspase-3  and  cleave  downstream  targets.  Cellular 
apparatus exists to keep such low-level caspase activities in check.
Neurons  are  reported  to  use  this  intrinsic  (mitochondrial)  pathway  of 
apoptosis,  although  there  are  notable  exceptions  which  use  receptor  directed 
apoptosis (Raoul,  Henderson, and  Pettmann  1999;  Schneider et al.  1999).  Mice 
which  are  null  for  either  Apaf-1  of  caspase-9  exhibit  gross  encephalic 
malformations due to the lack of apoptosis in neuronal cell populations (Kuida et 
al.  1998;  Cecconi  et  al.  1998).  Deletion  or  impairment  of  Bax,  another  gene 
involved  in  the  intrinsic  pathway  also  results  in  reduced  programmed  neuronal 
cell death,  and enables survival of nerve growth factor withdrawal (Deckwerth et 
al.  1996).
4.1.6  Evidence for RET as a dependence receptor:
As mentioned above RET possesses characteristics found in other known 
dependence receptors, namely involvement in nervous system development, and 
tumour  susceptibility.  It  has  been  previously  shown  that  RET  behaves  in  the 
manner  of  a  dependence  receptor  in  vitro  using  293T  cells  (Bordeaux  et  al.
2000).  In  these  studies  expression  of  RET  in  the  absence  of  its  ligand  GDNF 
resulted  in  increased  levels  of  cell  death.  Introducing  GDNF  to  293T  cells 
expressing  RET eliminated this effect and  imposed  a  slight increase  in  survival 
compared to controls. These results are similar to those found for the relationship
117between  DCC and  its ligand  netrin-1.  During  investigations  into DCC’s role as a 
dependence  receptor  it was  observed  that  it  acts  as  a  caspase  substrate  with 
cleavage occuring at Asp1290 (Mehlen et al.  1998).  Mutating this site resulted in 
suppression  of  the  proapoptotic  effect  of  DCC  expression  in  the  absence  of 
netrin-1.  Investigating  RET  led  to  a  similar  mechanism  being  proposed  for  its 
function.  RET also acts as a caspase substrate and  is cleaved  at two positions, 
Asp 708,  and Asp  1017 by caspase-3 (Bordeaux et al.  2000).  Mutation of either 
site  resulted  in  suppression of the proapoptotic effect of RET in the absence of 
GDNF. The domain between Asp708 and Asp1017 does not share any similarity 
with the proapoptotic domain of DCC bordered by Asp1290, or indeed any other 
dependence receptor.
4.1.7  A mechanism for RET induced apoptosis:
As discussed  in section 4.1.3 effector Caspases are  not produced  in  an 
active form  but in the form of inactive pro-caspase zymogens. These zymogens 
do  not  possess  sufficient  activity  to  be  responsible  for  cleaving  either  RET  or 
DCC in the context described  above. A novel  mechanism for caspase activation 
is  required for the apoptosis seen  arising from the expression  of either DCC  or 
RET in the absence of their respective ligands.
The mechanism of DCC induced apoptosis has been studied and  reveals 
a possible mechanism for novel caspase activation (Mehlen et al.  1998; Forcet et 
al.  2001).  It was  shown that caspase-3  activation  in  DCC  dependent apoptosis 
was  independent of caspase  8,  Apaf-1  and  cytochrome-c,  yet dependent  upon
118caspase-9.  This  removes  the  possibility  of  an  intrinsic  pathway  dependent 
system such as is detailed in Fig 4.2.  Both caspase-3 and caspase-9 have been 
shown  to  interact  with  DCC  in  conjunction  with  DCC-interacting  protein  13a 
(DIP13a).  Whether  this  interaction  is  direct  or  indirect  is  unclear  but  the 
interactions were  complementary:  Caspase-9  interacted  with  DCC  in  conditions 
of ligand absence and caspase-3 interacted with  DCC in the presence of ligand. 
Together  these  data  suggest  conformational  change  by  DCC  in  response  to 
ligand binding which acts to modulate a novel method of caspase activation and 
proteolytic cleavage.
RET  may  induce  apoptosis  by  a  similar  method.  It  is  known  that  RET 
dimerises when bound to its ligand GDNF and this may act to mask the caspase 
cleavage  sites  through  a  conformational  change  in  the  structure  of  the 
intracellular domain.  Equally,  though  no  evidence  yet  exists  to  directly  support 
this, RET may interact either directly or indirectly with caspase-3 and/or caspase- 
9 to initiate its own proteolytic cleavage in the absence of GDNF.
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Figure 4.2: A possible system  by which  ligand withdrawal from  RET may induce 
apoptosis:
One  effect  of  RET-GDNF  interaction  is  that  the  release  of  cytochrome  c  from 
mitochondria is inhibited by the PDK-1,  Bad route shown.  In the absence of RET 
signalling  to  PI(3)K this does  not occur and  leads to cytochrome  c release  and 
apoptosome assembly.  In turn  caspase-3  is activated  and  can  cleave  unbound 
RET  releasing  the  apoptotic  fragment.  This  leads  to  an  amplification  of  the 
apoptotic response. Bax* indicates activated Bax.
1204.1.8 Aims:
RET,  the  tyrosine  kinase  receptor,  displays  properties  of a  dependence 
receptor.  In  vitro  studies  indicate  that  failure  of  RET  to  bind  its  ligand  GDNF 
result  in  the  release  of  a  pro-apoptotic  fragment,  in  a  caspase  dependent 
manner,  which  induces  cell  death.  The  aim  of  this  study  was  to  investigate 
whether  the  perturbation  of  RET  expression,  and  the  caspase-dependent 
cleavage events associated with the in vitro studies,  altered the formation of the 
ENS  in  vivo.  Using  the  chick  model,  into  which  constructs  can  be  readily 
electroporated into premigratory neural crest, immediate and long-term effects on 
ENS development can be studied.
Four constructs were used to test the in vivo model;  1) PcDNA3 control; 2) 
RET9IC-wt,  a  truncated  form  of  human  wildtype  RET  consisting  of  only  the 
intracellular  domain;  3)  RET9IC-D707N,  the  same  intracellular  region  as  the 
wildtype RET but with a single point mutation at position 707; 4) Caspase-9DN, a 
dominant negative form  of caspase-9.  The  purpose  of the  point mutation  in the 
third  construct  was  to  prevent  caspase  cleavage  at  that  site  thus  preventing 
release of a pro-apoptotic fragment (Fig 4.3).
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Figure 4.3: Caspase cleaves wildtype RET but not RET with mutation D707N.
When  bound  to  its  co-receptor  and  ligand,  RET  forms  a  dimer, 
autophosphorylates  and  adopts  a  conformation  which  masks  the  caspase 
cleavage  sites  at  positions  708  and  1018.  These  caspase  cleavage  sites  are 
available in  unbound, monomeric, wildtype  RET.  Cleavage results in the release 
of a pro-apoptotic fragment. A single point mutation at position 707 removes the 
ability of caspase-3 to cleave at position 708 and prevents the release of the pro­
apoptotic fragment.
122Introducing  the  dominant  negative  caspase-9  allele  construct  should 
prevent  all  intrinsic  pathway  initiated  apoptosis.  Accepting  that  neuronal 
programmed  cell death operates almost exclusively by this pathway, this should 
reveal any apoptosis undergone by vagal neural crest cell populations.
The RET9IC-wt construct presents as a substrate for activated caspase-3. 
Introducing this should result in increased cell death if signals independent of the 
RET  pathway  initiate  a  caspase  cascade.  Should  RET  activation  act  as  a 
modulator  of  such  apoptotic  activity  RET9IC-wt  will  initiate  apoptosis  in  cells 
normally destined to die and increased neural crest cell numbers should result.
Through  the  introduction  of  RET9IC-D707N,  a  control  for  RET9IC-wt  is 
provided.  The  point mutation  conveying  resistance to  caspase  cleavage should 
result in no increase in apoptosis within neural crest cells.
1234.2 Results
4.2.11n situ analysis of Sox 10 expression within enteric precursors:
Sox10  was  used  as  a  marker  of  neural  crest  cells  to  establish  a 
benchmark against which  the expression  of ret in  NCC  could  be  compared.  At 
E2.5 sox10 was expressed in vagal derived migratory neural crest cells within the 
region of the otic vesicle and pharyngeal arches (Fig 4.4 A,B)  Trunk neural crest 
in the early stages of migration also expressed sox 10 and appeared as two lines 
running parallel to the midline (Fig 4.4 C). Neural crest cells were seen migrating 
as streams  between  somites from this  region  of the  neural tube. At  E3.5 sox10 
expression  was  present  in  the  area  around  the  otic  vesicle  and  within  the 
developing dorsal root ganglia (Fig 4.4 D,E).
At  E4.5  sox10  expression  was  present  within  vagal  derived  enteric 
precursors and was not detected  in sacral derived  neural crest (Fig 4.4 F). The 
extrinsic, neural crest derived, vagus nerves also expressed sox10 (Fig 4.4 F,G). 
sox10  expression  was  seen  throughout  the  length  of  the  gut,  including 
oesophagus, proventriculus and stomach (Fig 4.4 F-H).
124Figure 4.4: In Situ hybridisation  with sox10 probe.
(A)  At  E2.5  sox10 expression  was  present  in  the  region  of the  otic vesicle,  3rd  
pharyngeal arch, pharynx and in two lines parallel to the midline through the level 
of the truck. (B) High power image of the vagal region showing crest cells around 
the otic vesicle (asterisk) and pharynx (arrowhead). (C) sox 10 expression in early 
migratory neural crest of the truck level.  Crest cells were seen migrating through 
the  anterior  part  of  somites  (arrowheads).  (D)  sox10  expression  at  E3.5  was 
difficult  to  assess  in  the  region  of  the  pharyngeal  arches,  some  staining  was 
visible around the otic vesicle.  (E) High power showing sox10 expressing cells in 
forming  DRGs  at  E3.5  (arrowheads).  (F)  At  E4.5  sox10 expressing  cells  were 
present  within  the  foregut  and  vagus  nerves  (arrowheads).  (G)  Higher  power 
image  showing  expression  in  oesophagus,  proventriculus  and  stomach.  Also 
expressing  sox10 were the  neural  crest derived  vagus  nerves  (arrowhead).  (H) 
sox10 expressing cells within the stomach.
Scale bars: 0.25mm C,H; 0.5mm A,B,E;  1mm D,F,G.
1254.2.2 In situ analysis of Ret expression within ENS precursors:
The  precise  expression  patterns  of  ret  within  pre  and  post  migratory 
populations  of  neural  crest  cells  in  the  chick  were  determined.  Embryos  were 
collected at daily intervals between E1.5 and 4.5, and the gut dissected free from 
E4.5 embryos.
At  E1.5  (stage  HH10),  the time  used to electroporate vagal  neural  crest, 
ret expression was observed as a gradient within the neural tube (Fig 4.5 A,B) 
The most rostral point of expression, rhombomere 6, displayed the highest levels 
of ret expression. Expression levels were maintained at their peak throughout the 
length of rhombomere 6 and declined gradually between somites 1   and 5.
At  E2.5  strong  ret expression  was  present  in  the  migratory  neural  crest 
located around the otic vesicle and within the second, third and fourth pharyngeal 
(branchial)  arches  (Fig  4.5  C,D).  A  small  number  of  ret expressing  cells  was 
present caudal to these regions in the location of the developing foregut (Fig 4.5 
C’).  No  ret expression  was  seen  within  the  neural  tube  at  the  level  of  sacral 
neural crest at this stage.
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127Figure 4.5:  In Situ hybridisation with ret probe.
(A,B)  at  HH10,  prior to  neural  crest  migration,  ret was  expressed  in  the  neural 
tube from the level of the hindbrain to somite 5.  (C) E2.5 embryo, ret expression 
in the region of otic vesicle (ov),  second and third  pharyngeal arches (pa2,  pa3) 
and weakly in the fourth. (C’) Higher power image of boxed region in (C) showing 
a small cluster of ret expressing cells in the region of the developing foregut.  (D) 
close up of the region around pharyngeal arch 2 showing ret expression.  (E) ret 
positive cells were present throughout the pharyngeal arches, pharynx (ph) and a 
diffuse region of staining was present in the developing foregut (arrowhead).  (F) 
High  power image of foregut from  (E).  (G)  Dissected  gut from  an  E4.5 embryo, 
ret expressing  cells  were  present  in  the  stomach  (arrowhead)  and  forming  the 
nerve of Remak (arrow). (H) ret positive sacral derived crest cells which form the 
nerve  of  Remak  expressed  ret  and  had  migrated  rostral  to  the  caecal  buds 
(asterisks).  (H’)  transverse  section from  position  of dotted  line  in  (H)  confirmed 
staining of the nerve of Remak.  (I) Staining of migrating vagal  neural crest cells 
was present in the stomach.
Scale bars: 0.25mm B,D,F; 0.5mm A,C,E,H,I; 1mm G.
At  E3.5  strong  ret expression  was  present within  the  pharyngeal  arches 
(Fig 4.5 E).  Increased numbers of ref-expressing cells were present in the region 
of the developing foregut but their location appeared unchanged (Fig 4.5 F).
ret expression  in the guts of E4.5 embryos was  present within vagal and 
sacral derived populations of neural crest cells (Fig 4.5 G).  Extrinsic fibres of the 
vagus nerve were also seen attached to the oesophagus of dissected gut. Sacral 
derived  neural  crest  cells  had  begun  to  form  the  nerve  of  Remak  and  had 
migrated  beyond  the  caecal  buds  (Fig  4.5  H).  Strong  ret expression  could  be 
seen throughout the length of the forming  nerve of Remak. Transverse sections 
of this region confirm the ref-expressing cells to be the nerve of Remak (Fig 4.5 
H’).  Expression  of  ret  within  vagal  derived  neural  crest  cell  populations  was 
restricted  to  the  stomach  (Fig  4.5  I).  No  ret  expression  was  observed  in  the
128oesophagus  or lungbuds,  structures which  should  already  have  been  colonised 
by neural crest cells.
4.2.3  TuneI analysis:
In  order  to  identify  apoptotic  cells  within  neural  crest  cell  populations 
destined  to form  the  ENS,  Tunel  staining  was  employed.  Early stage  E1.5  and 
E2.5  embryos  were  investigated  as  there  is  currently  a  paucity  of  information 
regarding apoptosis in ENS precursor populations during migration in the gut.
At stage HH10 apoptotic cells were observed along a significant portion of 
the neural tube (Fig 4.6 A). The “salt and  pepper” appearance of Tunel positive 
cells was  limited  almost exclusively to the  dorsal  aspect  of the  neural  tube.  At 
E2.5 Tunel positive cells could be seen in the regions surrounding the otic vesicle 
through which vagal neural crest cells migrate (Fig 4.6 B,C).
129Figure 4.6: Tunel staining of E1.5 and E2.5 chick embryos.
(A) Tunel positive cells were located along the midline of the embryo in a pattern 
consistent with  neural  crest  formation.  An  area  of  highest  positive  cell  density 
was located  between somites 2 and 7, the region corresponding to vagal  neural 
crest. (B) Tunel positive cells were located in the region of migrating neural crest 
cells around the otic vesicle (arrow). Tunel cells were also seen in the dorsal tips 
of somites in the trunk region (arrowheads). (C) Tunel positive cells in the region 
of neural crest cells migrating towards branchial arch 3 (arrowhead),  and ventro- 
posteriorly towards the 3rd  pharyngeal pouch (arrow).
(Scale bars:  1mm.)
4.2.4  Electroporation of vagal neural crest does cells:
Electroporation  is an  invasive  procedure for early stage embryos.  Thus  it 
was  first  checked  that  electroporated  neural  crest  cells  were  viable,  migrated 
successfully  along  established  pathways  and  survived  to  form  the  ENS.  To  do 
this a  GFP  reporter was electroporated  into  HH10 embryos  in the  region  of the 
vagal neural crest (Fig 4.7) and embryos were screened at E2.5 when NCC were 
migrating towards the gut and at E6 when NCC were forming the ENS within the 
gut.  Wholemount  fluorescence  and  cryosections  revealed  neural  crest  cells 
migrating  successfully  from  the  neural  tube  at  E2.5  along  the  recognised 
dorsoventral  pathway  used  by  enteric  precursors  (Fig  4.8  A,B).  At  E6  GFP 
positive cells were present in the stomachs of electroporated animals (Fig 4.8 C) 
implying that survival of this population is not affected.
130Figure 4.7: Electroporation of HH10 chick embryos.
Reporter  and  experimental  plasmids  were  injected  into  the  neural  tube  at  the 
level of the third-fourth somites.  Fast green was used to visualise the progress of 
the injected solution which is allowed to fill the region between somites  1   and 7. 
When  placing  the  electrodes  the  anode  was  positioned  above  the  level  of the 
cathode. This  results  in  a flow of current,  and  hence  DNA,  into the more dorsal 
aspect of the neural tube.
Figure 4.8:  GFP  labelled  neural crest-derived  cells  migrate and  survive  in  chick 
embryos.
GFP-labelled  cells  migrate  and  colonise  the  gut  in  chick  embryos  after 
electroporation.  (A)  E2.5 chick embryo 24 hours post electroporation,  crest cells 
are migrating  past the visceral  pouch  (Arrow).  (B)  12um cryosection  reveals the 
ventral  path  taken  by  GFP-labelled  crest  cells.  (C)  GFP-labelled  cells  form 
primitive ganglia (Arrows) in the stomach of E8 chicks (Arrowhead-mucosa).
131To  ensure  that  the  process  of  electroporation  itself  did  not  affect  ENS 
formation, the neural crest of E1.5 embryos was subjected to electroporation with 
the  control  plasmid  PcDNA3  on  both  sides  of the  neural  tube  in  an  effort  to 
electroporate  the  majority  of  ENS  precursors.  Embryos  were  again  screened 
using a GFP marker 24  hours later for success of the procedure. The formation 
of the  ENS was  compared  to that of unelectroporated  embryos  at  E14.5  using 
wholemount NADPH diaphorase staining to visualise NOS neurons along the gut 
length  (Fig  4.9).  These  comparisons  revealed  no  difference  in  the formation  of 
the NOS-neuron networks between these animals.
4.2.5  Electroporation with Caspase-9DN results in an abnormal neural tube and 
increased numbers of neural crest cells:  (The number of embryos studied was 
12)
In  contrast to  a  normal  neural  tube,  which  possesses  a  rounded  dorsal 
midline,  the  majority of caspase-9DN  electroporated  embryos  (7/9)  displayed  a 
slender protrusion or ridge (Fig 4.10). This ridge appeared to co-incide with only 
the  region  subject  to  electroporation,  with  the  remaining  neural  tube 
demonstrating  a  normal  morphology.  Interestingly,  despite  only one  side  of the 
neural  tube  having  been  electroporated  this  ridge  contained  tissue  from  the 
control side in addition to GFP positive tissue.
Sections  immunofluorescently stained for the  neural  crest marker HNK-1 
revealed  that the  numbers  of neural  crest cells  migrating  on  the electroporated 
side of the embryo were increased. To visualise this further 3D reconstruction of
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Figure 4.9: Electroporation does not affect ENS formation.
Electroporation  with  the  control  vector  PcDNA3  results  in  a  normal  enteric 
phenotype at E14.5 as shown by NADPH-diaphorase staining for NOS neurons. 
Scale Bars: 20pm excluding stomach 1mm
1333D Reconstruction of serial sections
Figure  4.10:  Electroporation  with  Caspase-9DN  results  in  an  abnormal  neural 
tube and increased NCC numbers.
(A)  Control  electroporations  retained  the  rounded  appearance  of  the  dorsal 
aspect  of  the  neural  tube  (arrow)  at  E2.5.  (B)  However,  Caspase-9DN 
electroporated  embryos  exhibited  a  pronounced  protrusion  from  the  dorsal 
midline in the region of electroporation  (arrow).  (C,D)  3D  reconstruction  of serial 
cryostat  sections  from  a  Caspase-9DN  electroporated  embryo.  (C)  GFP  was 
expressed  on  the  right-hand  side  indicating  successful  electroporation,  the  left- 
hand side serves as a control. (D) HNK-1  staining for migratory neural crest cells 
revealed  more  neural  crest  cells  on  the  electroporated  side  (arrowhead)  in 
comparison to the control side.serial  sections was  used  to generate a  model which  could  be  manipulated  and 
the differences between populations compared.
4.2.6  Electroporation  with  Caspase-9DN  results  in  hyperganglionosis  of  the 
foregut: (The number of embryos studied was 4)
To  investigate whether inhibiting  the  activity of caspase-9,  and  therefore 
cell death,  was capable of generating  an enteric phenotype,  the  neural  crest of 
embryos  was  electroporated  at  E1.5  on  both  sides  of  the  neural  tube.  After 
screening, embryos were left until E14.5, at which time their guts were dissected 
and prepared for NADPH staining as described in methods section 2.10.
50%  (2  of  4)  of  the  animals  which  survived  to  this  late  stage  (E14.5) 
displayed an enteric phenotype. Whilst the hindgut and  midgut of these animals 
appeared  normal  when  compared  to  controls  their  foreguts  were  distinctly 
different (Fig  4.11).  The  oesophagus  and  crop  of Caspase-9DN  electroporated 
animals  displayed  hyperganglionosis.  This  hyperganglionosis  appears  as  a 
network  of  ganglia  of  greater  size  and  number  than  that  present  in  controls. 
Despite  these  changes  in  number  and  size  the  overall  pattern  of  ganglia 
appeared relatively normal possessing a honeycomb like structure.
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Figure  4.11:  Caspase-9DN  treated  embryos  display  hyperganglionosis  of  the 
foregut.
Caspase-9DN  electroporated  embryos  shown  in  the  right-hand  column  display 
hyperganglionosis  of the  oesophagus when  compared  to  controls  (left column). 
This  hyperganglionosis  does  not  continue  along  the  full  length  of the  gut;  cell 
numbers appear normal in the midgut and hindgut.
Scale Bars: 20pm excluding stomach 1mm
Caspase-9DN
1364.2.7 Electroporation  with RET9-ICwt and RET9-ICD707N produce no apparent 
phenotype at E2.5: (The number of embryos studied was 20)
No  gross  phenotypic  change  involving  neural  tube  morphology  was 
observed  in  embryos  electroporated  with  RET9-ICwt  or  RET9-ICD707N. 
Furthermore  no difference  in  migrating  neural crest cell  number or position was 
observed at E2.5.
4.2.8  Electroporation  with  RET9-ICwt  does  not  produce  a  different  enteric 
phenotype: (The number of embryos studied was 5)
Embryos electroporated with  RET9-ICwt on both sides of the neural tube, 
analysed  at  E14.5  using  NADPH  staining,  displayed  no  difference  in  enteric 
phenotype compared to controls.  NOS neuron number and overall ENS structure 
appeared normal.
4.2.9  Electroporation  with  RET9-ICD707N  in  quail/chick  chimeras  results  in  a 
delay of migration by neural crest cells and an associated ectopic plexus:  (The 
number of embryos studied was 3)
As the GFP marker had been demonstrated to be diluted out of the 
NCC  by  E8  due  to  their  highly  proliferative  nature,  attempts  were  made  to 
combine the electroporation  procedure with a quail/chick interspecies graft. This 
was  done  to  enable  both  highly  specific  targeting  of the  vagal  crest,  and  the 
subsequent  tracing  of  these  cells  using  the  anti-quail  cell  antibody  QCPN.
137Electroporated  /  grafted  embryos  were  assessed  by  immunohistochiemical 
staining using the QCPN marker on cryosections.
Data were acquired for PcDNA3 and  RET9-ICD707N graft/electroporation 
combinations. PcDNA3 electroporated embryos appeared normal with no change 
in neural crest number or in their spatiotemporal colonisation of the gut. Embryos 
electroporated  with  RET9-ICD707N  displayed  a  delay  in  colonisation  of the gut 
(Fig 4.12 A-H).  In addition to this delay ectopic cells were observed in E9.5 and 
E12.5  embryos  (Fig  4.12  l,J). These ectopic cells were  located  in the  mucosal 
layer  below  the  submucosal  plexus  and  appeared  to  be  forming  an  additional 
ectopic plexus.
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Figure 4.12:  Migrational delay of enteric precursors  in quail/chick electroporations
(A,C,E)  sections  of hindgut  regions  corresponding  to those  indicated  in  (F)  taken 
from  quail/chick  grafts  at  E8.5.  (A)  At  position  1,  Q CPN  positive  cells  were 
present  in  the  submucosal  and  myenteric  plexi.  Migration  of  neural  crest  cells 
from  the  submucosal to  myenteric  plexus was just  beginning  at  position  2  (C).  At 
the  most  terminal  level  QCPN  positive  cells  were  present  in  the  submucosal 
plexus  (E).  In  comparison,  tissue  from  a  RET9-ICD707N  electroporated  graft  at 
position  1  contained  only  a  few  cells  in  the  submucosal  plexus  and  none  in  the 
myenteric.  No  Q CPN  positive  cells  were  found  caudal  of  position  2.  At  E9.5, 
QCPN  positive  cells  were  present  in  the  terminal  hindgut  of  electroporated 
embryos  (H)  and  were  migrating  towards the  myenteric plexus.  (I, J)  show ectopic 
plexi  within  electroporated  gut  arising  from  centripetal  migration  from  the 
submucosal  plexus.
1394.2.10 Electroporation with RET9-ICD707N results in a failure of enteric neurons 
to differentiate: (The number of embryos studied was 7)
Of the embryos successfully incubated  until  E14.5,  80% displayed a  lack 
of NADPH staining along a variable length of the gut. The region most commonly 
affected  extended  from  a  point  approximately  one  centimetre  caudal  to  the 
duodenal junction with the stomach, to the caecum.  In the most severe case (Fig 
4.13)  this  absence  of  NADPH  staining  extended  from  the  oesophagus  to  the 
terminal  hindgut.  Limited  NADPH  staining  was  observed  in  the  proventriculus 
(Fig 4.13 B) and one half of the terminal hindgut.
The  absence  of  NADPH  positive  staining  in  these  guts  is  further 
demonstrated  using flatmounted  sections  (Fig  4.14)  In  this  instance the  lack of 
NOS neurons in the oesophagus, crop, and midgut are clear.  Positive staining is 
present in the stomach although  it appears weaker and  reduced.  In the terminal 
hindgut NADPH staining appears comparable to the control.
Occasional isolated populations of NOS neurons could be seen amidst the 
long  stretches of otherwise  NADPH  staining  deficient  regions of gut (Fig 4.15). 
These “islands”  ranged  in  size from  single  rings of ganglia  (Fig 4.15  E) to  long 
regions of 20mm which were restricted to one side of the gut (Fig 4.15 A-D). In a 
number of the embryos recovered, the terminal hindgut contained  NOS neurons 
despite the  majority of the  mid  and  hindgut  lacking  them.  The transitional  zone 
between these two regions shows quite an abrupt front (Fig 4.15 F).
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Fig  4.13:  Absence  of  NADPH  staining  in  RET9IC -D707N  electroporated 
embryos:
Panels  A-F  compare  control  (bottom  tissue)  against  D707N  with  severe 
aganglionosis  (top  tissue).  A-F  correspond  to  regions  marked  in  panel  G.  A,C-F 
show  normal  NOS  neuron  networks  stained  by  NADPH  arranged  in  a  web-like 
formation.  In  comparison  the  D707N  tissue  in  these  panels  appear  pale  and 
devoid  of  NADPH  staining  indicating  the  absence  of  NOS  neurons.  B  shows 
normal  staining  in  the  stomach  of the  control  and  positive  staining  of  NADPH  in 
the  stomach  and  proventriculus.  The  stomach  also  appear  to  be  smaller  in  the 
D707N  embryo.
(Scale bars =  1mm)
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Fig 4.14:  Flatmounts of E14.5  RET9-ICD707N electroporated  gut compared to 
controls,  staining with  NADPH for NOS  neurons:
At E14.5 control embryos (Left hand column) display strong  positive  NADPH 
staining  along the full  length  of the gut.   In  comparison,  oesophagus,  crop and 
midgut of RET-ICD707N  electroporated  embryos (right hand  column)  lack  NOS 
neurons. Whilst positive staining  is found  in the stomach  and  hindgut of these 
RET9-ICD707N  embryos,  it is weaker and fewer cells are apparent.
Scale  Bars:  20pm excluding  stomach  1mm
142Figure 4.15:  NADPH  staining  and  expression  of NCC  and  neuronal  markers  in 
gut negative for NADPH-diaphorase staining.
(A-F) show unusual patterns of NADPH staining. (A/B) and (C/D) are examples of 
NADPH  staining  being  present  on  only  one  “side”   of  a  section  of  midgut  and 
hindgut respectively. (E) illustrates the appearance of an NADPH staining “island”  
consisting  of  a  single  ring  of ganglia.  (F)  the  transition  zone  between  NADPH 
negative gut and NADPH positive terminal hindgut.
(G)  immunohistochemical  staining for p75N TR  (red)  and  aSMA  (green)  illustrate 
that  neural  crest  derived  cells  were  located  in  the  myenteric  and  submucosal 
plexi of NADPH negative gut (arrowheads). (H) furthermore these cells were very 
weakly expressing PGP9.5, a neuronal differentiation marker (arrowheads).
(Scale bars (A-F) = 1mm.)
143To  investigate  whether this  lack  of  NADPH  staining  indicated  a  lack  of 
differentiated neurons or a lack of enteric precursors,  immunohistochemistry was 
performed using antibodies against p75N TR  and PGP9.5 on gut sections (Fig 4.15 
G,H).  Such  staining  revealed  that  in  regions  lacking  NADPH  reactivity  neural 
crest derived  cells were present (Fig 4.15 G) and some cells stained weakly for 
PGP9.5  indicating  that they  had  begun  to  differentiate towards  a  neuronal  fate 
(Fig 4.15 H).
1444.3 Discussion:
In  this  study  the  in  vivo  role  of  RET  as  a  dependence  receptor  was 
investigated  using  electroporation  of  chick  vagal  neural  crest  to  introduce 
constructs designed to perturb this proposed pathway.  In order to compare RET 
expression  with  the  location  of apoptotic cells  in  the early chick embryo  in situ 
hybridisation and Tunel staining techniques were employed.
Although the  receptor tyrosine kinase  RET has a well  established  role  in 
ENS  development  as  a  receptor  for  the  trophic  ligand  GDNF  (Durbec  et  al. 
1996a;  Natarajan et al.  2002) there is strong evidence for RET functioning  as a 
dependence receptor in vitro (Bordeaux et al. 2000).  However, the idea that RET 
could  function  as  a  dependence  receptor  had  not  been  tested  in  vivo to  date. 
Apoptosis has not been associated with the development of NCC derived enteric 
precursors, the extensive proliferation required to fully populate the gut from such 
a  small  initial  migratory  pool  makes  such  an  association  counter-intuitive. 
Therefore,  it  was  first  necessary  to  confirm  the  existence  of  apoptosis  within 
enteric precursor cell populations and to correlate this to the expression of RET 
in these same populations of cells.
In  situ  hybridisation  using  probes  for  ret  revealed  a  strong  expression 
domain  in  the  neural  tube  between  Rhombomere  6  and  somite  5.  This domain 
overlaps  with  the  location  of vagal  neural  crest  formation.  Similar  analysis  by 
Robertson  et al concurs with this finding.  These authors describe expression  in
145this region extending caudally to somite 7 (Robertson et al.  1995).  In addition to 
this domain, Robertson et al reported expression within the nephritic ducts and at 
the boundary of Rhombomeres 3 and 4.  It is possible that no ret expression was 
observed in the nephritic ducts in this work due to insufficient permeabilisation of 
the chick embryo which displays a robustness to this procedure.
To  complement  the  ret  in  situ  data,  Tunel  staining  was  performed  to 
compare ret expression with apoptosis in the developing embryo.  Here the use of 
Tunel  staining  at  HH10  revealed  apoptotic  cells  along  the  neural  tube  in  the 
region  of  the  forming  vagal  derived  neural  crest  and  at  the  boundary  of 
Rhombomeres  3  and  4.  This  correlates with  ret expression  patterns  seen  here 
and in previous work (Homma et al. 2000;  Schiltz,  Benjamin, and  Epstein  1999). 
No apoptotic cells were observed in the region of the nephritic ducts, a region of 
ret expression  as  described  by  Homma.  This  may  be  due  to  the  presence  of 
RET’s  receptor GDNF  in these structures  (Homma et al.  2000).  GDNF was  not 
found to be expressed  in the neural tube and  so it remains a possibility that the 
apoptosis present in the midline arises as a  result of the proposed  dependence 
receptor mechanism.
Tunel  positive  cells  were  present  in  the  streams  of  migrating  NCC,  as 
suggested  by  sox10  positive  in  situ,  around  the  otic  vesicle  at  E2.5.  Sox10 
positive  NCC  were  located  in  the  second  pharyngeal  arch  and  presumptive 
foregut regions, ret positive neural crest derived cells were present in the first and 
second  pharyngeal  arches and the presumptive foregut.  GDNF expression was 
found  at the boundaries between the pharyngeal arches and foregut mesoderm
146(Homma et al. 2000) correlating nicely with those regions of ret expression which 
did not overlap with Tunel staining.
The  patterns  of ret expression  at  E3.5  and  E4.5  revealed  an  interesting 
pattern  which  may  influence  the  migratory  behaviour of  ENS  precursors.  Most 
clearly  shown  at  E4.5,  the  expression  of ret by  migrating  ENS  precursors was 
restricted  to  the  caudal  most  cells  at  the  wavefront  of  colonisation.  ENS 
precursors  throughout  the  oesophagus  and  stomach  were  sox10  positive  but 
lacked ret expression.  In mice, strong ret expression  persists within cells behind 
the migration wavefront (Pachnis,  Mankoo,  and  Costantini  1993).  However,  only 
a subset of vagal derived  neural crest cells express  RET in the first instance  in 
the mouse (Anderson,  Stewart,  and Young 2005).  This suggests a fundamental 
difference  in  the  regulation  of  RET  expression  between  the  mouse  and  chick 
models.
Electroporation  is  a  well-established  method  for  introducing  genetic 
material  to the  chick  at early embryonic  stages.  Considerable  effort was  made 
here to  ensure that the  physical  procedure  of electroporation  did  not affect the 
development of the  neural  crest or other tissues.  In  validation  experiments,  the 
GFP  reporter  expressed  strongly  within  vagal  NCC  populations  and  could  be 
detected  in  tissues  six  days  after  electroporation.  GFP  labelled  cells  migrated 
along previously described pathways with no deviation in developmental timing or 
target location. Later embryos showed no clear difference in ENS formation when 
assessed  with  NADPH  staining  for  NOS  neurons  at  E14.5.  Thus  it  can  be
147concluded  that  electroporation  is  an  effective  and  accurate  method  for 
introducing DNA into NCC within chick embryos with no undesired side-effects.
The Caspase-9DN construct was used to investigate the effect of reducing 
cell death  in  developing  neural crest cell  populations. At  E2.5,  NCC were  more 
numerous  on the  side of embryos electroporated  with  Caspase-9DN  compared 
with  the  control  side.  At  E14.5  hyperganglionosis  of the  oesophagus  and  crop 
was  observed  using  NADPH  staining  compared  to  PcDNA3  electroporated 
controls.  This  confirms the  apoptosis  observed  in  the Tunel  staining  described 
earlier and implicates capase-9 in the activation of an effector caspase (caspase- 
3) by an unspecified means.
Caspase-9  was  shown  to  be  required  for the  cleavage  of  RET  in  vitro 
(Bordeaux et al.  2000),  but these results cannot implicate  RET in the apoptosis 
seen  here  as  caspase-9  is  involved  downstream  of the  RET  receptor and  may 
interact  with  other  proteins.  The  restriction  of  hyperganglionosis  arising  from 
Caspase-9DN  electroporation  to the foregut may be  as  a  result of the  plasmid 
expressing  the  caspase-9DN  construct  being  diluted  out  in  the  rapidly 
proliferating NCC population. The protocol establishing experiments revealed that 
GFP  expression  was  only  maintained  until  E8  at the  latest  and  few  GFP  cells 
were  rarely  observed  caudal  to  the  stomach.  Use  of  a  retroviral  capase-9DN 
vector could result in a hyperganglionosis of the entire ENS.
The  unusual  morphology of the surface ectoderm  and  dorsal  neural tube 
suggests  a  morphological  reason  for  apoptosis  occurring  at  the  HH10  stage.
148Apoptosis  of  cells  in  this  region  may  be  required  for  the  separation  of  the 
overlying  ectoderm  from  the  forming  mesenchymal  tissue.  Removal  of  the 
apparatus required for this prevents accurate sculpting of this region and leads to 
a protruding ridge in the affected area.
Experiments  were  performed  with  the  RET9IC-wt  construct  to  test  the 
hypothesis  that  ectopic  expression  of  this  intracellular  domain  would  provide 
sufficient  substrate  for  active  caspase-3  to  cleave  and  release  the  apoptotic 
fragment as  seen  in  vitro (Bordeaux et al.  2000).  However,  no  change  in  NCC 
number or in the structure of the ENS was observed.
Endogenous  RET  levels  were  not  altered  in  any  way  during  the 
experiment,  nor were the  receptor domains  blocked.  Thus  any  intrinsic survival 
signals which  NCCs were transducing may have overridden the apoptotic signal 
from the introduced  RET9IC-wt.  The only cells that might have been affected  in 
this case would  have been  non-RET expressing  cells  in the surrounding tissue, 
such as the mesenchyme, but no gross change in the survival of these cells was 
noted.  Introduction  of  small  interfering  RNAs  (siRNAs)  to  full  length  RET  or 
GDNF  at the  same time  as  RET9IC-wt  may circumvent this  effect should  it  be 
occurring.  The  siRNA would  inhibit translation  of the target  mRNA and  remove 
the supportive signalling.
Use of such a technique would result in a RET9 deficient phenotype which 
past  experiments  using  mice  have  demonstrated  to  result  in  an  aganglionic 
phenotype (de Graaff et al. 2001).  It may be impossible to restrict RET inhibition
149to  the  timeframe  in  which  it  is  hypothesised  that  it  plays  a  part  in  regulating 
apoptosis and not functioning in a chemotactic role.
The  RET9IC-D707N  construct was  intended to serve as a control for the 
RET9IC-wt  containing  plasmid.  However,  at  E8.5,  E9.5  and  E14.5  embryos 
electroporated  with  RET9IC-D707N  displayed  a  delay  in  migration  and 
differentiation  of  vagal  derived  NCC  enteric  precursors.  Electroporated  quail- 
chick grafts at  E8.5  possessed  a wavefront of vagal  derived  enteric precursors 
several  millimetres  behind  control  electroporated  grafts.  Whilst  cells  had 
successfully migrated to the submucosal and  myenteric plexi at the most caudal 
end  of  the  gut  by  E14.5,  NADPH  staining  revealed  that  cells  had  not  yet 
differentiated to a terminal neuronal phenotype.
A possible cause of the delay in migration and subsequently differentiation 
of  these  cells  could  be  due  to  interaction  of  the  endogenous  RET  with  the 
electroporated  RET9IC-D707N.  If these  receptors were,  for example,  forming  a 
heterodimer, then the autophosphorylation of RET and  subsequent downstream 
signalling  could  be  adversely affected.  Such  an  interaction  should  not  result  in 
cell  death  either as the  inappropriate  binding  of the two  alleles  would  alter the 
conformation  of  the  endogenous  RET  intracellular  domain  and  mask  the 
caspase-sensitive  cleavage  sites.  The  mutation  at  position  707  is  55  residues 
upstream  of  the  nearest  documented  mutation  that  induces  a  loss  of  kinase 
activity  (Manie  et  al.  2001).  To  investigate  this,  co-immunoprecipitation 
experiments  using  antibodies to the full  length  RET extracellular domain  and  a
150tag  on  RET9IC-D707N  would  reveal  whether  ligand-independent  binding 
between the two alleles is occurring.
The apparent ectopic plexus seen  in the quail/chick electroporated  grafts 
is  difficult  to  interpret  in  light  of  its  absence  from  electroporations  of  RET9IC- 
D707N  into  chicks.  It  may  be  that  this  effect  is  secondary  and  results  from 
additional delay in the migration of the neural crest cells  in the grafted embryos 
which leads to a failure of these cells to respond correctly to environmental cues.
151Concluding Statement:
The  work  contained  within  this  thesis  addresses  two  separate  issues 
concerning  ENS  development.  Whilst the  immunohistochemical  analysis  of the 
formation of a normal functioning ENS in humans stands as a complete work, the 
investigation  into  RET’s  role  as  a dependence  receptor has developed  into the 
beginning  of a  larger body of work  requiring  further analysis to fully dissect the 
potential roles of RET during ENS development.
Characterising spatiotemporal pattern of colonisation and development of 
the gastrointestinal tract with  respect to the  ENS,  ICCs,  and  smooth  muscle  in 
the human revealed similarities between human patterns and that of mammalian 
models.  Whilst  some  of the  timepoints  used  in  this  study  overlap  with  similar 
works  there  are  significant  differences  in  the  findings  between  the  studies.  It 
would  be  interesting  to  now  go  on  to  use  this  information  to  investigate  the 
signals  and  physical  boundaries  controlling  neural  crest colonisation  of the gut. 
Using tissue culture methods to grow lengths of human gut alongside a source of 
ENS  precursors,  the  precise  window  for  the  successful  migration  and 
development of NCC into a functioning ENS may be found.  It may be possible to 
use  this  knowledge  to  develop  cell-based  therapies  for  ENS  defects  such  as 
Hirschsprung’s  disease  and  achalaisa.  Knowing  which  signalling  molecules  are 
required  to  promote  sufficient  proliferation  of  introduced  ENS  precursors  to 
aganglionic  gut  and  their  subsequent  differentiation  would  be  key  to  this. 
Understanding the physical limitations to ENS precursor migration would provide 
an indication of the best locations / physical spacing to inject such cells.
152The  second  part  of  this  thesis,  investigating  the  role  of  RET  as  a 
dependence  receptor  in  ENS  formation,  produced  some  interesting  and  yet 
confounding  results.  Certainly further work  is  required  to  address the  issues  of 
interaction  between endogenous  RET and  introduced,  truncated  alleles of RET. 
The  multiple  roles  of  RET  in  survival,  migration,  and  apoptosis  mean  that 
investigating  any  one  function  without  disrupting  the  others  is  very  complex. 
Interactions between RET alleles may adversely affect downstream signalling or 
autophosphorylation  of the  protein.  Although  the  role  of RET as  a dependence 
receptor gains no direct support from in vivo work, the circumstantial evidence is 
mounting.  Apoptosis  and  RET expression  co-inciding  at  appropriate  timepoints 
and  the  demonstration  that  capase-9  dependent  apoptosis  occurs  within  early 
vagal  neural  crest  populations,  can  only  serve  to  increase  support  for  RET 
playing a dependence receptor role in vivo.
Given  sufficient time to continue this investigation, there are a  number of 
key areas one would wish to address; the lack of a phenotype using  RET9IC-wt 
and the delay in migration and differentiation seen with RET9IC-D707N would be 
ideal  starting  points.  Although  the  phenotype  observed  with  RET9IC-D707N  is 
very interesting, the more important of these two points to resolve would  be the 
generation  of  a  RET9IC-wt  phenotype.  To  do  so  electroporation  of  siRNAs 
specific to the full  length  form  of RET should  be  performed  in  conjunction with 
electroporation of the RET9IC-wt plasmid. This technique would adversely affect 
the  chemotactic  roles  of  RET  later  in  development  compounding  possible 
phenotypes and making analysis of late stages challenging.  However, the use of 
this technique to observe initial changes in neural crest cell number at E2.5 in themanner  used  for  the  Caspase-9DN  construct  seems  valid.  Successful 
electroporation  of  these  constructs  could  result  in  increased  apoptosis  in  the 
forming  vagal  neural  crest.  Removal  of  endogenous  RET  transduced  survival 
signals  would  allow  the  cleavage  of  the  introduced  RET  allele  to  induce  cell 
death  via  release of the  pro-apoptotic fragment.  This could then  be  rescued  by 
electroporating Caspase-9DN at the same time point. The use of three modifying 
constructs  and  a  reporter gene would  present a  significant technical  challenge, 
especially if each was on a separate construct. The combination of two or more 
constructs into a single plasmid would probably be necessary to convince critics 
of the  ability to  target  large  numbers  of individual  cells  with  all  of the  required 
factors.
Approaching the second component of this investigation with the benefit of 
hindsight, significant changes to the systems employed would be used. The use 
of  late  stage  embryonic  material  to  investigate  ENS  phenotypes  was  unwise 
lacking  sufficient  data  concerning  changes  to  the  initial  neural  crest  cell 
populations when subjected to electroporation. By employing an in vivo approach 
to  the  early  effects  of  the  various  constructs  quantitative  observations  were 
restricted  and  the  acquisition  of  data  was  substantially  more  difficult  than  by 
certain  in  vitro  methods.  The  initial data  concerning  cell  number and  behaviour 
within  targeted  vagal  neural  crest cell  populations  should  be done  using  neural 
tube cultures allowing time-lapse photography of the behaviour of these cells and 
easy quantification  of cell  number and  migration  ability as determined  by speed 
and distance.  Full in vivo experimentation should then be persued with sufficient 
supporting data from these experiments.
154The constructs themselves would  ideally be redesigned to incorporate an 
IRES site and associated GFP sequence to guarantee association between GFP 
expression and the presence of the test construct.  In the event that the construct 
proved too large to read through the IRES site reliably then a tag such as a triple 
Myc  sequence  should  be  attached  to  the  experimental  construct  to  allow 
identification by antibody staining.
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